var title_f31_27_32176="Patient information: Prostate cancer screening (PSA tests) (The Basics)";
var content_f31_27_32176=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"topicTitle\">",
"   Patient information: Prostate cancer screening (PSA tests) (The Basics)",
"  </div>",
"  <a href=\"./authors-and-editors/patient-information\">",
"   Written by the doctors and editors at UpToDate",
"  </a>",
"  <br/>",
"  <br/>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 15, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H29810060\">",
"    <span class=\"h1\">",
"     What is prostate cancer screening?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prostate cancer screening is a way in which doctors check the prostate gland for signs of cancer. In men, this gland sits below the bladder and in front of the rectum. It forms a ring around the urethra, the tube that carries urine out of the body (",
"    <a class=\"graphic graphic_figure graphicRef65675 \" href=\"mobipreview.htm?36/32/37382\">",
"     figure 1",
"    </a>",
"    ). (Women do not have a prostate gland.)",
"   </p>",
"   <p>",
"    The main test used to screen for prostate cancer is a blood test called a &ldquo;PSA test.&rdquo; Some men also have an exam called a rectal exam (",
"    <a class=\"graphic graphic_figure graphicRef80412 \" href=\"mobipreview.htm?12/30/12768\">",
"     figure 2",
"    </a>",
"    ). Prostate cancer screening is done in men who have no symptoms of the disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29810067\">",
"    <span class=\"h1\">",
"     Who should be screened for prostate cancer?",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not clear whether getting screened for prostate cancer can extend a man&rsquo;s life or help him avoid any symptoms or problems. For this reason, doctors do not know who&mdash;if anyone&mdash;should be screened for prostate cancer.",
"   </p>",
"   <p>",
"    Most experts recommend that each man work with his doctor to decide whether screening is right for him. In most cases, men should start discussing prostate cancer screening around the age of 50. Most doctors recommend against screening for men age 75 or older, or for men with serious health problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29810074\">",
"    <span class=\"h1\">",
"     Why do doctors offer screening?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doctors offer screening in the hopes of catching prostate cancer early&mdash;before it has a chance to grow, spread, or cause symptoms. With many cancers, catching the disease early is an important part of effective treatment. But prostate cancer is not like many other cancers. It usually grows slowly and does not usually lead to death. The problem is that a small number of prostate cancers",
"    <strong>",
"     are",
"    </strong>",
"    serious and can lead to death. Doctors have no ideal way to tell which prostate cancers are deadly and which ones would never cause any problems. Certain tests can suggest which prostate cancers might be more likely to cause problems. But the tests are far from perfect.",
"   </p>",
"   <p>",
"    To make matters more confusing, different studies draw different conclusions about the benefits of prostate cancer screening. One big study found that screening lowers the risk of dying from prostate cancer. Another big study found that it does not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29810081\">",
"    <span class=\"h1\">",
"     What are the drawbacks to getting screened?",
"    </span>",
"    &nbsp;&mdash;&nbsp;PSA tests have 2 main drawbacks:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PSA tests sometimes give &ldquo;false positives,&rdquo; meaning they indicate cancer when there is no cancer. This can lead to unneeded worry and to further tests&mdash;including 1 test (a biopsy) that can be painful. &nbsp;",
"     </li>",
"     <li>",
"      When PSA tests lead to the discovery of cancer, there is no way to tell whether the cancer is one that could do harm. That means that men sometimes get treated for cancers that would not have done them any harm. That&rsquo;s a problem because treatment for prostate cancer has risks and often causes problems of its own. For instance, prostate cancer treatment can cause men to leak urine and to have problems with sex. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29810088\">",
"    <span class=\"h1\">",
"     How do I decide if I should be screened?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Work with your doctor or nurse to decide if screening is right for you. As you are deciding, think about how likely it is that you will get prostate cancer. Black men and men who have a brother or father with the disease are more likely than other men to get it. For men with a high risk of prostate cancer, screening might be a good idea.",
"   </p>",
"   <p>",
"    Think, too, about how you feel about the possible benefits and harms of being screened. Ask yourself:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Do I want to know if I have prostate cancer, even if the cancer might never do me any harm?",
"     </li>",
"     <li>",
"      Would I be treated if I learned that I had prostate cancer?",
"     </li>",
"     <li>",
"      How do I feel about the risks of being treated for prostate cancer?",
"     </li>",
"     <li>",
"      How do I feel about the risks of getting a deadly or aggressive form of prostate cancer?",
"     </li>",
"     <li>",
"      Would I be willing to accept a high risk of side effects from treatment in return for a small chance of living longer?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29810095\">",
"    <span class=\"h1\">",
"     What is a PSA test?",
"    </span>",
"    &nbsp;&mdash;&nbsp;PSA stands for &ldquo;prostate-specific antigen.&rdquo; PSA is a protein made by the prostate. Levels of this protein go up when a man has prostate cancer. The protein also goes up for reasons that do NOT involve cancer. For example, PSA levels rise when a man:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Has a condition called benign prostatic hyperplasia (BPH), sometimes called an enlarged prostate",
"     </li>",
"     <li>",
"      Has a prostate infection, also called prostatitis",
"     </li>",
"     <li>",
"      Hurts his prostate, for example while riding a bike",
"     </li>",
"     <li>",
"      Ejaculates (has an orgasm)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    You should avoid ejaculating or riding a bike for at least 2 days before having a PSA test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29810102\">",
"    <span class=\"h1\">",
"     What if my PSA level is too high?",
"    </span>",
"    &nbsp;&mdash;&nbsp;If your PSA level is high, do not panic. It&rsquo;s possible your PSA is high for reasons unrelated to cancer. The first thing to do is to have the PSA test again. Remember, it&rsquo;s important that you avoid ejaculating and bike-riding for 2 days before the test. If your doctor thinks you have a prostate infection, you might also need to take antibiotics for a while before you repeat the test.",
"   </p>",
"   <p>",
"    If your PSA is still high on the second test, you will probably need a biopsy. That means that a doctor will insert a needle into your prostate to take tiny samples of tissue. Those samples will then go to the lab to be checked for cancer.",
"   </p>",
"   <p>",
"    If it turns out you do have cancer, remember that prostate cancer is not usually deadly. It usually grows slowly, so you probably have time to decide what to do. There are treatments that can sometimes cure prostate cancer. But men sometimes hold off on having treatment and wait to see if their cancer shows signs of progressing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29810109\">",
"    <span class=\"h1\">",
"     How often should a man be screened for prostate cancer?",
"    </span>",
"    &nbsp;&mdash;&nbsp;For those who decide to be screened, experts recommend starting at age 50 and repeating screening very 2 to 4 years. Men with risk factors for prostate cancer (such as black men or men with a family history of prostate cancer) may want to begin screening at age 40 to 45.",
"   </p>",
"   <p>",
"    Men can stop being screened when they turn 75 or if they develop serious health problems. &nbsp;In these cases, the benefits of screening are not worth the possible harms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29810237\">",
"    <span class=\"h1\">",
"     More on this topic",
"    </span>",
"   </p>",
"   <p>",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/63/10227?source=see_link\">",
"     Patient information: Cancer screening (The Basics)",
"    </a>",
"   </p>",
"   <p>",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/3/2099?source=see_link\">",
"     Patient information: Prostate cancer (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/15/3315?source=see_link\">",
"     Patient information: Choosing treatment for low-risk localized prostate cancer (The Basics)",
"    </a>",
"   </p>",
"   <p>",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/21/15698?source=see_link\">",
"     Patient information: Benign prostatic hyperplasia (enlarged prostate) (The Basics)",
"    </a>",
"   </p>",
"   <p>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/55/38770?source=see_link\">",
"     Patient information: Prostate cancer screening (Beyond the Basics)",
"    </a>",
"   </p>",
"   <p>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/41/42643?source=see_link\">",
"     Patient information: Treatment for advanced prostate cancer (Beyond the Basics)",
"    </a>",
"   </p>",
"   <p>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/39/40565?source=see_link\">",
"     Patient information: Prostate cancer treatment; stage I to III cancer (Beyond the Basics)",
"    </a>",
"   </p>",
"   <p>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/51/28467?source=see_link\">",
"     Patient information: Benign prostatic hyperplasia (BPH) (Beyond the Basics)",
"    </a>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16191 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"footerNav\">",
"   <ul>",
"    <li>",
"     <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Wolters Kluwer Health",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Facts &amp; Comparisons&reg;",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"      Medi-Span&reg;",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"      ProVation&reg; Order Sets",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"      ProVation&reg; Medical",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Pharmacy OneSource&reg;",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"      Medicom",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Lexicomp",
"     </a>",
"    </li>",
"    <li class=\"last\">",
"     <a href=\"/home/privacy-policy\">",
"      Privacy Policy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <div id=\"footerLogo\">",
"   <a href=\"./toc\">",
"    Wolters Kluwer Health | UpToDate",
"   </a>",
"  </div>",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"sfInfo\">",
"    <a href=\"/home/terms-use\">",
"     Terms of Use",
"    </a>",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     UpToDate Marketing Professional",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-79.122.249.114-09BE62CB2E-14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32176=[""].join("\n");
var outline_f31_27_32176=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29810060\">",
"      What is prostate cancer screening?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29810067\">",
"      Who should be screened for prostate cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29810074\">",
"      Why do doctors offer screening?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29810081\">",
"      What are the drawbacks to getting screened?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29810088\">",
"      How do I decide if I should be screened?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29810095\">",
"      What is a PSA test?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29810102\">",
"      What if my PSA level is too high?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29810109\">",
"      How often should a man be screened for prostate cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29810237\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   GRAPHICS",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     FIGURES",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/32/37382\" title=\"figure 1\">",
"      Prostate anatomy PI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/30/12768\" title=\"figure 2\">",
"      Rectal exam PI",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/51/28467?source=related_link\">",
"      Patient information: Benign prostatic hyperplasia (BPH) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/21/15698?source=related_link\">",
"      Patient information: Benign prostatic hyperplasia (enlarged prostate) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/63/10227?source=related_link\">",
"      Patient information: Cancer screening (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/15/3315?source=related_link\">",
"      Patient information: Choosing treatment for low-risk localized prostate cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/3/2099?source=related_link\">",
"      Patient information: Prostate cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/55/38770?source=related_link\">",
"      Patient information: Prostate cancer screening (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/39/40565?source=related_link\">",
"      Patient information: Prostate cancer treatment; stage I to III cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/41/42643?source=related_link\">",
"      Patient information: Treatment for advanced prostate cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_27_32177="ETT confirm colorimetry";
var content_f31_27_32177=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F71442%7EEM%2F58659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F71442%7EEM%2F58659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 485px\">",
"   <div class=\"ttl\">",
"    Universal tube placement confirmation with Colorimetric CO",
"    <sub>",
"     2",
"    </sub>",
"    detectors",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 465px; height: 458px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Clinical maneuvers, such as auscultation (chest, epigastric) and direct laryngoscopy may be utilized at physician discretion, but clinicians must be aware of their limitations in discriminating between esophageal and tracheal intubation.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 491px\">",
"   <div class=\"ttl\">",
"    Universal tube placement confirmation with capnography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 471px; height: 459px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Based on the clinical situation, provider may choose to remove the tube or obtain a secondary confirmation measure.",
"     <br>",
"      &bull; Clinical maneuvers, such as auscultation (chest, epigastric) and direct laryngoscopy may be utilized at physician discretion, but clinicians must be aware of their limitations in discriminating between esophageal and tracheal intubation.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32177=[""].join("\n");
var outline_f31_27_32177=null;
var title_f31_27_32178="Pappenheimer bodies";
var content_f31_27_32178=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F51160&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F51160&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Siderocyte containing Pappenheimer bodies in sideroblastic anemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral smear from a patient with clonal sideroblastic anemia, showing a population of hypochromic and microcytic red cells. One hypochromic red cell (arrow) has three iron-containing inclusions, called Pappenheimer bodies.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sylvia Bottomley, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32178=[""].join("\n");
var outline_f31_27_32178=null;
var title_f31_27_32179="Child vs adult airway 2";
var content_f31_27_32179=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F62656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F62656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Child versus adult airway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 406px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The anatomical differences particular to children are (a) higher, more anterior position of the glottic opening (note the relationship of the vocal cords to the chin/neck junction); (b) relatively larger tongue in the infant, which lies between the mouth and glottic opening; (c) relatively larger and more floppy epiglottis in the child; (d) the subglottic region as the functionally narrowest portion of the pediatric airway versus the vocal cords in the adult; (e) position and size of the cricothyroid membrane in the infant; (f) sharper, more difficult angle for blind nasotracheal intubation; and (g) larger relative size of the occiput in the infant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Luten RC, McAllister JD. Approach to the pediatric airway. In: Manual of Emergency Airway Management, 3rd edition, Walls RM, Murphy MF (Eds), Lippincott Wilkins and Williams, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32179=[""].join("\n");
var outline_f31_27_32179=null;
var title_f31_27_32180="Pulsus alternans and pulsus paradoxus arterial waveforms";
var content_f31_27_32180=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F70731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F70731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Pulsus alternans and pulsus paradoxus arterial waveforms",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 658px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In pulsus alternans, which is associated with severe left ventricular systolic dysfunction, there is variation in the amplitude of the systolic arterial pressure with every other beat. In contrast, pulsus paradoxus varies with the respiratory cycle, such that the duration of arterial pressure reduction is sustained during the inspiratory portion of the respiratory cycle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Barry A Borlaug, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32180=[""].join("\n");
var outline_f31_27_32180=null;
var title_f31_27_32181="Physiology of gonadotropin-releasing hormone";
var content_f31_27_32181=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Physiology of gonadotropin-releasing hormone",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/27/32181/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32181/contributors\">",
"     Corrine K Welt, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/27/32181/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32181/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32181/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/27/32181/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32181/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/27/32181/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Control of the reproductive axis originates in the hypothalamus with the periodic",
"    <strong>",
"     pulsatile",
"    </strong>",
"    release of gonadotropin-releasing hormone (GnRH). In response to GnRH (also called luteinizing hormone releasing hormone or LHRH), the pituitary releases pulses of the gonadotropins,",
"    <strong>",
"     luteinizing hormone",
"    </strong>",
"    (LH) and",
"    <strong>",
"     follicle-stimulating hormone",
"    </strong>",
"    (FSH), into the blood stream. These hormones then induce gonadal production of a variety of hormones, such as estradiol, progesterone, and testosterone, that play an important role in the regulation of reproduction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RELEASE OF GNRH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several elements are necessary for the normal release of and response to GnRH: migration of the secretory neurons via the proper route to the proper location must take place in the developing embryo and secretion must occur in a pulsatile fashion in response to neuroendocrine inputs and sex steroids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Embryonic migration",
"    </span>",
"    &nbsp;&mdash;&nbsp;GnRH is released from a small number of hypothalamic neurons that appear to arise in the developing embryo from an epithelial cluster of cells in the olfactory placode outside the central nervous system, although recent evidence in zebrafish suggest the neurons arise from the anterior pituitary placode and cranial neural crest, then transiently associate with the olfactory placode [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Regardless of their site of origin, fetal cells in the olfactory area can respond to odorant stimuli and secrete GnRH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/4\">",
"     4",
"    </a>",
"    ]. These neurons then migrate into the olfactory bulb and olfactory tract before continuing to move into the medio-basal hypothalamus in the preoptic area and the arcuate nucleus.",
"   </p>",
"   <p>",
"    Migration is an essential feature of developing GnRH neurons as demonstrated by studies in which the GnRH neurons in fetal hypothalamic tissue were transplanted to the floor of the third ventricle in GnRH-deficient (hpg) mice. The GnRH neurons migrated to the correct hypothalamic location and sent projections to the median eminence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The critical role of migration has been confirmed in humans in a study of an aborted human fetus with Kallmann syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/6\">",
"     6",
"    </a>",
"    ]. The fetus had the same X chromosome deletion as its living GnRH-deficient brother. Neuropathologic examination showed arrest of the GnRH neurons at the cribriform plate of the ethmoid sinus at a time when the GnRH neurons in a normal fetus would have already migrated to the hypothalamus. Anosmin-1, the protein encoded by the KAL1 gene responsible for X-linked Kallmann syndrome, plays a role in GnRH neuronal migration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/7\">",
"     7",
"    </a>",
"    ]. The fibroblast growth factor receptor 1 (FGFR1) also plays a role in GnRH neuronal migration, and mutations in FGFR1 and its ligand FGF8 are associated with Kallmann syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. The association of GnRH neurons with the olfactory bulb and tract is thought to explain the high frequency of anosmia (lack of smell) in patients with GnRH deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Other gene mutations resulting in GnRH deficiency are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/7/2170?source=see_link\">",
"     \"Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pulsatile GnRH secretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;For proper stimulation of gonadotropin release, GnRH neurons must be properly located and must secrete in a pulsatile fashion (",
"    <a class=\"graphic graphic_waveform graphicRef77183 \" href=\"mobipreview.htm?38/32/39438\">",
"     waveform 1",
"    </a>",
"    ). Some GnRH neuron axons terminate on cell bodies of other GnRH neurons, suggesting a mechanism for coordinate control of pulsatility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/13\">",
"     13",
"    </a>",
"    ]. In addition, immortalized GnRH neurons in vitro continue to release GnRH in a pulsatile fashion, suggesting the existence of an intrinsic hypothalamic pulse generator [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Appropriate pulsatile release of GnRH stimulates the release of LH and FSH. In turn, the pattern of LH and FSH release induces gonadal production of steroid hormones, including the steroids estradiol, progesterone, testosterone, and androstenedione, and other factors, such as the protein hormones inhibin, activin, and insulin-like growth factor-I (IGF-I).",
"   </p>",
"   <p>",
"    The control of GnRH release is complex. There appears to be a pulse generator that coordinates the secretion of GnRH in discrete, random, but regular bursts. Multiple neurotransmitters and neurohormones have been implicated as having a role in the control of GnRH secretion, including catecholamines, opiates, neuropeptide Y, galanin, corticotropin-releasing hormone, and prolactin, as well as gonadal steroids.",
"   </p>",
"   <p>",
"    Sex steroids have both positive and negative feedback effects on GnRH pulse frequency. How this occurs is not well understood. Sex steroid receptors have been difficult to identify in hypothalamic GnRH-secreting neurons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/15,16\">",
"     15,16",
"    </a>",
"    ] and their existence remains controversial. However, estrogen receptors have been found in adjacent cells in the hypothalamus. Glial cells have steroid hormone receptors and are likely to be intimately involved in transmitting sex steroid feedback (and other signals) to GnRH neurons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The GPR54 gene, which encodes a G-protein coupled receptor, appears to be important for normal hypothalamic GnRH processing or secretion. Mutations in this gene have been reported in some patients with congenital GnRH deficiency without anosmia (idiopathic hypogonadotropic hypogonadism, or IHH). Mutations in neurokinin B and its receptor have also been reported in patients with congenital IHH and may work through kisspeptin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/7/2170?source=see_link\">",
"     \"Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pulsatile gonadotropin response",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency and amplitude of LH pulses is a crucial component of normal reproductive development and maintenance. On the other hand, disruption of the normal pattern of pulsations is associated with multiple disorders of human reproduction. Thus, understanding the pathophysiology of reproductive disorders requires some assessment of the pulsatility of GnRH secretion. Since the hypothalamus and the portal blood supply are not safely accessible, an alternate method is required, such as measuring serum LH as a marker of GnRH secretion.",
"   </p>",
"   <p>",
"    Each pulse of LH measured in the peripheral blood corresponds to a hypothalamic pulse of GnRH into the portal system in a one-to-one relationship (",
"    <a class=\"graphic graphic_waveform graphicRef77183 \" href=\"mobipreview.htm?38/32/39438\">",
"     waveform 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/19\">",
"     19",
"    </a>",
"    ]. As an example, GnRH-deficient men and women have no pulses of LH detected in their peripheral blood; they will, however, respond to exogenous GnRH with a pulse of LH for each pulse of GnRH given [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/20\">",
"     20",
"    </a>",
"    ]. Prolonged administration of pulses of GnRH in these patients can lead to normal pubertal development and the ability to conceive. Although FSH is released with LH, FSH pulses are much more difficult to detect because the half-life of FSH is longer than the interval between GnRH pulses.",
"   </p>",
"   <p>",
"    The requirement for stimulation of the pituitary gonadotrophs to secrete FSH and LH by pulses of GnRH has been documented by frequent blood sampling in many experimental models [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/21,22\">",
"     21,22",
"    </a>",
"    ] and by the administration of GnRH to GnRH-deficient humans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/20\">",
"     20",
"    </a>",
"    ]. The response is different if GnRH is administered continuously. Then, serum gonadotropin concentrations temporarily increase (the agonist effect) and then decrease in response to desensitization (",
"    <a class=\"graphic graphic_figure graphicRef51212 \" href=\"mobipreview.htm?19/58/20398\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/20,22,23\">",
"     20,22,23",
"    </a>",
"    ]. The development of desensitization has become",
"    <strong>",
"     important clinically",
"    </strong>",
"    as long-acting GnRH agonists (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/61/26580?source=see_link\">",
"     nafarelin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/22/9574?source=see_link\">",
"     goserelin",
"    </a>",
"    ) are being used to suppress gonadotropin and therefore sex steroid release in a variety of conditions including precocious puberty, prostate cancer, breast cancer, uterine fibroids, and endometriosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32181/abstract/24-28\">",
"     24-28",
"    </a>",
"    ]. When the agonist is withdrawn, spontaneous GnRH pulses resume, leading to restoration of gonadotropin pulsations and gonadal responses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PHYSIOLOGIC FUNCTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pattern of GnRH, LH, and FSH pulses appears to regulate a variety of important functions including the onset of human sexual differentiation and puberty, as well as adult sex steroid production and fertility.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In women, FSH promotes follicular development whereas LH is critical for ovulation and maintenance of the corpus luteum. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27685?source=see_link\">",
"       \"Physiology of the normal menstrual cycle\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In men, LH is generally responsible for stimulating testosterone production from the Leydig cells in the testes. FSH, in concert with high intratesticular testosterone levels, is required for spermatogenesis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ensuing release of gonadal hormones then has modulating effects on both hypothalamic and pituitary function:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Estradiol, progesterone, and testosterone feedback negatively to reduce the release of LH and FSH; these effects appear to occur at both pituitary and hypothalamic sites of action.",
"     </li>",
"     <li>",
"      Inhibin suppresses FSH more than LH synthesis and secretion, while activin stimulates FSH release.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One can therefore use the combination of serum gonadotropin and sex steroid values to determine if a defect in reproductive function is due to an abnormality of the gonads or to an abnormality in the hypothalamic or pituitary release of gonadotropins. Serum sex steroid concentrations will be low in patients with both disorders, but serum gonadotropin concentrations will be high in patients with gonadal dysfunction (due to loss of negative feedback) and low in those with hypothalamic or pituitary disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?10/14/10468?source=see_link\">",
"       \"Patient information: Infertility treatment with gonadotropins (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H239062188\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Control of the reproductive axis originates in the hypothalamus with the periodic pulsatile release of gonadotropin-releasing hormone (GnRH). In response to GnRH, the pituitary releases pulses of the gonadotropins, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) into the blood stream. These hormones then induce gonadal production of a variety of hormones, such as estradiol, progesterone, and testosterone, that play an important role in the regulation of reproduction.",
"   </p>",
"   <p>",
"    The following elements are necessary for the normal hypothalamic secretion of and pituitary response to GnRH:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      GnRH neurons must be properly located; migration of the secretory GnRH neurons takes place in the developing embryo. These neurons then migrate into the olfactory bulb and olfactory tract before continuing to move into the medio-basal hypothalamus in the preoptic area and the arcuate nucleus. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Embryonic migration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      GnRH secretion must occur in a pulsatile fashion in response to neuroendocrine inputs and sex steroids. There appears to be a pulse generator that coordinates the secretion of GnRH in discrete, random, but regular bursts. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pulsatile GnRH secretion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pituitary has an absolute requirement that GnRH secretion be pulsatile in order to secrete LH and FSH (",
"      <a class=\"graphic graphic_waveform graphicRef77183 \" href=\"mobipreview.htm?38/32/39438\">",
"       waveform 1",
"      </a>",
"      ). Continuous, rather than pulsatile, administration of GnRH results in pituitary desensitization (",
"      <a class=\"graphic graphic_figure graphicRef51212 \" href=\"mobipreview.htm?19/58/20398\">",
"       figure 1",
"      </a>",
"      ). This observation is the basis for the clinical use of GnRH agonists, which are used to suppress gonadotropin secretion and therefore gonadal steroids in a variety of conditions including precocious puberty, prostate cancer, breast cancer, uterine fibroids, and endometriosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pulsatile gonadotropin response'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/1\">",
"      Schwanzel-Fukuda M, Jorgenson KL, Bergen HT, et al. Biology of normal luteinizing hormone-releasing hormone neurons during and after their migration from olfactory placode. Endocr Rev 1992; 13:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/2\">",
"      Schwanzel-Fukuda M, Pfaff DW. Origin of luteinizing hormone-releasing hormone neurons. Nature 1989; 338:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/3\">",
"      Whitlock KE. Origin and development of GnRH neurons. Trends Endocrinol Metab 2005; 16:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/4\">",
"      Barni T, Maggi M, Fantoni G, et al. Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells. J Clin Endocrinol Metab 1999; 84:4266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/5\">",
"      Gibson MJ, Krieger DT, Charlton HM, et al. Mating and pregnancy can occur in genetically hypogonadal mice with preoptic area brain grafts. Science 1984; 225:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/6\">",
"      Schwanzel-Fukuda M, Bick D, Pfaff DW. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 1989; 6:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/7\">",
"      Soussi-Yanicostas N, Faivre-Sarrailh C, Hardelin JP, et al. Anosmin-1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. J Cell Sci 1998; 111 ( Pt 19):2953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/8\">",
"      Tsai PS, Moenter SM, Postigo HR, et al. Targeted expression of a dominant-negative fibroblast growth factor (FGF) receptor in gonadotropin-releasing hormone (GnRH) neurons reduces FGF responsiveness and the size of GnRH neuronal population. Mol Endocrinol 2005; 19:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/9\">",
"      Dod&eacute; C, Levilliers J, Dupont JM, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003; 33:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/10\">",
"      Falardeau J, Chung WC, Beenken A, et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 2008; 118:2822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/11\">",
"      Kallman, FJ, Schoenfeld, WA, Barrera, SE. The genetic aspects of primary eunoichidism. Am J Ment Defic 1944; 48:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/12\">",
"      Spratt DI, Carr DB, Merriam GR, et al. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab 1987; 64:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/13\">",
"      Chen WP, Witkin JW, Silverman AJ. beta-Endorphin and gonadotropin-releasing hormone synaptic input to gonadotropin-releasing hormone neurosecretory cells in the male rat. J Comp Neurol 1989; 286:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/14\">",
"      Wetsel WC, Valen&ccedil;a MM, Merchenthaler I, et al. Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. Proc Natl Acad Sci U S A 1992; 89:4149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/15\">",
"      Skynner MJ, Sim JA, Herbison AE. Detection of estrogen receptor alpha and beta messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons. Endocrinology 1999; 140:5195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/16\">",
"      Roy D, Angelini NL, Belsham DD. Estrogen directly respresses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons. Endocrinology 1999; 140:5045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/17\">",
"      Ojeda SR, Ma YJ. Glial-neuronal interactions in the neuroendocrine control of mammalian puberty: facilitatory effects of gonadal steroids. J Neurobiol 1999; 40:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/18\">",
"      Topaloglu AK, Reimann F, Guclu M, et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet 2009; 41:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/19\">",
"      Clarke IJ. Variable patterns of gonadotropin-releasing hormone secretion during the estrogen-induced luteinizing hormone surge in ovariectomized ewes. Endocrinology 1993; 133:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/20\">",
"      Crowley WF Jr, Filicori M, Spratt DI, Santoro NF. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 1985; 41:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/21\">",
"      Weiss J, Duca KA, Crowley WF Jr. Gonadotropin-releasing hormone-induced stimulation and desensitization of free alpha-subunit secretion mirrors luteinizing hormone and follicle-stimulating hormone in perifused rat pituitary cells. Endocrinology 1990; 127:2364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/22\">",
"      Belchetz PE, Plant TM, Nakai Y, et al. Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science 1978; 202:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/23\">",
"      Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogues. N Engl J Med 1991; 324:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/24\">",
"      Crowley WF Jr, Comite F, Vale W, et al. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981; 52:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/25\">",
"      Labrie F, Dupont A, B&eacute;langer A, et al. Treatment of prostate cancer with gonadotropin-releasing hormone agonists. Endocr Rev 1986; 7:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/26\">",
"      Klijn JG, de Jong FH, Lamberts SW, Blankenstein MA. LHRH-agonist treatment in clinical and experimental human breast cancer. J Steroid Biochem 1985; 23:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/27\">",
"      Filicori M, Hall DA, Loughlin JS, et al. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol 1983; 147:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32181/abstract/28\">",
"      Barbieri RL. New therapy for endometriosis. N Engl J Med 1988; 318:512.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7438 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-89.218.100.194-EFEE8658EB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32181=[""].join("\n");
var outline_f31_27_32181=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H239062188\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RELEASE OF GNRH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Embryonic migration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pulsatile GnRH secretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pulsatile gonadotropin response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PHYSIOLOGIC FUNCTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H239062188\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7438\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7438|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/58/20398\" title=\"figure 1\">",
"      Continuous GnRH LH and FSH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7438|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?38/32/39438\" title=\"waveform 1\">",
"      Pulsatile GnRH and LH release",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/7/2170?source=related_link\">",
"      Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?10/14/10468?source=related_link\">",
"      Patient information: Infertility treatment with gonadotropins (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27685?source=related_link\">",
"      Physiology of the normal menstrual cycle",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_27_32182="Secobarbital: Drug information";
var content_f31_27_32182=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Secobarbital: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/55/28532?source=see_link\">",
"    see \"Secobarbital: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/13/21718?source=see_link\">",
"    see \"Secobarbital: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F220193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Seconal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F220211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Barbiturate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F220196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Insomnia (hypnotic):",
"     </b>",
"     Oral: Usual: 100 mg at bedtime.",
"     <b>",
"      Note:",
"     </b>",
"     Limit to short-term use only; efficacy for sleep induction and maintenance is lost after 14 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Preoperative sedation:",
"     </b>",
"     Oral: 200-300 mg 1-2 hours before procedure",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F220197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. Manufacturer's labeling recommends a dose reduction, but does not provide specific dosing recommendations.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F220198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Manufacturer's labeling recommends a dose reduction, but does not provide specific dosing recommendations.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F14721461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Manufacturer's labeling recommends a dose reduction, but does not provide specific dosing recommendations.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F220172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as sodium:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Seconal&reg;: 100 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F220157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F220213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-II",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F220174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Preanesthetic agent; short-term treatment of insomnia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F220218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Seconal&reg; may be confused with Sectral&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - high; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F220209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%: Central nervous system: Somnolence (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Abnormal thinking, agitation, angioedema, anxiety, apnea, ataxia, bradycardia, CNS depression, complex sleep-related behavior (sleep-driving, cooking or eating food, making phone calls), confusion, constipation, dizziness, exfoliative dermatitis, fever, hallucinations, headache,  hyperkinesis, hypotension, hypoventilation, insomnia, liver injury, megaloblastic anemia, nausea, nervousness, nightmares, pain at injection site, rash, syncope, unusual excitement, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F220177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to barbiturates or any component of the formulation; marked hepatic impairment; dyspnea or airway obstruction; porphyria",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F220161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Postmarketing studies have indicated that the use of hypnotic/sedative agents for sleep has been associated with hypersensitivity reactions including anaphylaxis as well as angioedema.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Paradoxical responses: May cause paradoxical responses, including agitation and hyperactivity, particularly in acute pain, chronic pain and pediatric patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sleep-related activities: An increased risk for hazardous sleep-related activities such as sleep-driving; cooking and eating food, and making phone calls while asleep have also been noted. Discontinue treatment in patients who report a sleep-driving episode.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease; may cause hypotension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Depression: Use with caution in patients with depression or suicidal tendencies.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with respiratory disease; may cause respiratory depression.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use due to risk of overdose with low dosages, tolerance to sleep effects, and increased risk of physical dependence (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Use with caution in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Symptomatic treatment of insomnia should be initiated only after careful evaluation of potential causes of sleep disturbance. Failure of sleep disturbance to resolve after 7-10 days may indicate psychiatric and/or medical illness.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Abrupt cessation may precipitate withdrawal, including status epilepticus in epileptic patients.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F220207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Induces",
"     </b>",
"     CYP2A6 (strong), CYP2C8 (strong), CYP2C9 (strong)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F220166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetaminophen: Barbiturates may increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Barbiturates may decrease the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Atenolol; Levobunolol; Metipranolol; Nadolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Barbiturates may increase the metabolism of Calcium Channel Blockers.  Management: Monitor for decreased therapeutic effects of calcium channel blockers with concomitant barbiturate therapy. Calcium channel blocker dose adjustments may be necessary. Nimodipine Canadian labeling contraindicates concomitant use with phenobarbital.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Clevidipine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloramphenicol: Barbiturates may increase the metabolism of Chloramphenicol. Chloramphenicol may decrease the metabolism of Barbiturates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): Barbiturates may diminish the therapeutic effect of Contraceptives (Estrogens). Contraceptive failure is possible.  Management: Use of a non-hormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): Barbiturates may diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible.  Management: Use of alternative, nonhormonal contraceptives is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Barbiturates may decrease the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Barbiturates may increase the metabolism of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2A6 Substrates: CYP2A6 Inducers (Strong) may increase the metabolism of CYP2A6 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Substrates: CYP2C8 Inducers (Strong) may increase the metabolism of CYP2C8 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Substrates: CYP2C9 Inducers (Strong) may increase the metabolism of CYP2C9 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diclofenac (Systemic): CYP2C9 Inducers (Strong) may decrease the serum concentration of Diclofenac (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: Barbiturates may increase the metabolism of Disopyramide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: May decrease the metabolism of Barbiturates. Barbiturates may decrease the serum concentration of Divalproex.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Doxycycline: Barbiturates may decrease the serum concentration of Doxycycline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Enzalutamide: CYP2C8 Inducers (Strong) may decrease the serum concentration of Enzalutamide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etoposide: Barbiturates may decrease the serum concentration of Etoposide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etoposide Phosphate: Barbiturates may decrease the serum concentration of Etoposide Phosphate. Barbiturates may increase the metabolism, via CYP isoenzymes, of etoposide phosphate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Felbamate: Barbiturates may decrease the serum concentration of Felbamate. Felbamate may increase the serum concentration of Barbiturates.  Management: Monitor for elevated barbiturate concentrations/toxicity if felbamate is initiated/dose increased, or reduced concentrations/effects if felbamate is discontinued/dose decreased. Refer to phenobarbital dosing guidelines for patients receiving that agent.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Barbiturates may enhance the CNS depressant effect of Fosphenytoin. Barbiturates may decrease the serum concentration of Fosphenytoin. Fosphenytoin may increase the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Griseofulvin: Barbiturates may decrease the serum concentration of Griseofulvin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of Barbiturates. Management: Consider a decrease in the barbiturate dose, as appropriate, when used together with hydroxyzine.  With concurrent use, monitor patients closely for excessive response to the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     LamoTRIgine: Barbiturates may decrease the serum concentration of LamoTRIgine.  Management: See lamotrigine prescribing information for specific age-dependent dosing guidelines regarding concurrent use with a barbiturate, as well as for adjusting lamotrigine dosing if concurrent barbiturate therapy is discontinued.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Meperidine: Barbiturates may enhance the CNS depressant effect of Meperidine. Barbiturates may increase serum concentrations of the active metabolite(s) of Meperidine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Barbiturates may enhance the CNS depressant effect of Methadone. Barbiturates may decrease the serum concentration of Methadone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May enhance the CNS depressant effect of Barbiturates. Barbiturates may decrease the serum concentration of Phenytoin. Phenytoin may increase the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Primidone: May enhance the adverse/toxic effect of Barbiturates. Primidone is converted to phenobarbital, and thus becomes additive with existing barbiturate therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: Barbiturates may decrease the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pyridoxine: May increase the metabolism of Barbiturates. Apparent in high pyridoxine doses (eg, 200 mg/day)",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Barbiturates may enhance the hepatotoxic effect of QuiNIDine. Barbiturates may decrease the serum concentration of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Teniposide: Barbiturates may decrease the serum concentration of Teniposide.  Management: Consider alternatives to combined treatment with barbiturates and teniposide due to the potential for decreased teniposide concentrations.  If the combination cannot be avoided, monitor teniposide response closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Barbiturates may decrease the serum concentration of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Barbiturates may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Treprostinil: CYP2C8 Inducers (Strong) may decrease the serum concentration of Treprostinil.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: Barbiturates may increase the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: May decrease the metabolism of Barbiturates. Barbiturates may decrease the serum concentration of Valproic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Barbiturates may increase the metabolism of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F220190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid valerian, St John's wort, kava kava, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F220167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10924210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Barbiturates can be detected in the placenta, fetal liver, and fetal brain. Fetal and maternal blood concentrations may be similar following parenteral administration. An increased incidence of fetal abnormalities may occur following maternal use. When used during the third trimester of pregnancy, withdrawal symptoms may occur in the neonate including seizures and hyperirritability; symptoms may be delayed up to 14 days. Use during labor does not impair uterine activity; however, respiratory depression may occur in the newborn; resuscitation equipment should be available, especially for premature infants.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F220201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F10924211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Small amounts of barbiturates are found in breast milk.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F5989463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Seconal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $1712.53",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F220169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, heart rate, respiratory rate, CNS status; liver function, renal function",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Dormatylan (AT);",
"     </li>",
"     <li>",
"      Seconal Sodium (GB)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F220160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Depresses CNS activity by binding to barbiturate site at GABA-receptor complex enhancing GABA activity, depressing reticular activity system; higher doses may be gabamimetic",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F220176\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of hypnosis: Oral: 10-15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Oral: 3-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic, by microsomal enzyme system",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 15-40 hours, mean: 28 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (as inactive metabolites, small amounts as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/27/32182/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/27/32182/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levine HL, Cohen ME, Duffner PK, et al, &ldquo;Rectal Absorption and Disposition of Secobarbital in Epileptic Children,&rdquo;",
"      <i>",
"       Pediatr Pharmacol (New York)",
"      </i>",
"      , 1982, 2(1):33-8.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Monteil RA, Raybaud H, Madinier I, et al, &ldquo;Occurrence of Oral Mucosal Necrosis in a Patient With Barbiturate-Induced Coma,&rdquo;",
"      <i>",
"       Oral Surg Oral Med Oral Pathol",
"      </i>",
"      , 1991, 72(5):562-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/27/32182/abstract-text/1745515/pubmed\" id=\"1745515\" target=\"_blank\">",
"        1745515",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nahata MC, Starling S, and Edwards RC, &ldquo;Prolonged Sedation Associated With Secobarbital in Newborn Infants Receiving Ventilatory Support,&rdquo;",
"      <i>",
"       Am J Perinatol",
"      </i>",
"      , 1991, 8(1):35-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/27/32182/abstract-text/1987965/pubmed\" id=\"1987965\" target=\"_blank\">",
"        1987965",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tracqui A, Kintz P, Mangin P, et al, &ldquo;A Fatality Involving Secobarbital, Nitrazepam, and Codeine,&rdquo;",
"      <i>",
"       Am J Forensic Med Pathol",
"      </i>",
"      , 1989, 10(2):130-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/27/32182/abstract-text/2741867/pubmed\" id=\"2741867\" target=\"_blank\">",
"        2741867",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wolfert RR and Cox RM, &ldquo;Room Temperature Stability of Drug Products Labeled for Refrigerated Storage,&rdquo;",
"      <i>",
"       Am J Hosp Pharm",
"      </i>",
"      , 1975, 32(6):585-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/27/32182/abstract-text/1155470/pubmed\" id=\"1155470\" target=\"_blank\">",
"        1155470",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9880 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-52D7E7C181-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32182=[""].join("\n");
var outline_f31_27_32182=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220193\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220211\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220196\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220197\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220198\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14721461\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220172\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220157\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220213\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220174\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220218\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220209\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220177\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220161\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220207\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220166\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220190\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220167\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10924210\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220201\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10924211\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5989463\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220169\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038824\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220160\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220176\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9880\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9880|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/55/28532?source=related_link\">",
"      Secobarbital: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/13/21718?source=related_link\">",
"      Secobarbital: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_27_32183="Surgical management of mediastinal lymphadenopathy";
var content_f31_27_32183=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management of mediastinal lymphadenopathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/27/32183/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32183/contributors\">",
"     Michael J Liptay, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32183/contributors\">",
"     Edward Hong, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32183/contributors\">",
"     Adam J Braze, DO",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/27/32183/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32183/contributors\">",
"     Joseph S Friedberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/27/32183/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32183/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/27/32183/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H548647065\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of mediastinal nodes is paramount for staging patients with suspected or proven bronchogenic carcinomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/1\">",
"     1",
"    </a>",
"    ]. The operative procedures are the gold standard approach for evaluating mediastinal adenopathy and for establishing the diagnosis of a primary or secondary mediastinal malignancy (eg, lymphoma, thymoma, breast cancer).",
"   </p>",
"   <p>",
"    The operative approach for evaluation of mediastinal lymphadenopathy and the complications of the procedures are discussed here. The differential diagnosis, radiographic evaluation, and pathology of mediastinal masses are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/24/31111?source=see_link\">",
"     \"Evaluation of mediastinal masses\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/40/32392?source=see_link\">",
"     \"Anterior mediastinal mass lesions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=see_link\">",
"     \"Pathology of mediastinal tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H548647079\">",
"    <span class=\"h1\">",
"     CLASSIFICATION MEDIASTINAL LYMPH NODES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mediastinal lymph nodes are located in the anterior, middle, and posterior mediastinal compartments (",
"    <a class=\"graphic graphic_figure graphicRef56896 \" href=\"mobipreview.htm?17/32/17923\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef69492 \" href=\"mobipreview.htm?14/38/14948\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/24/31111?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation of mediastinal masses\", section on 'Mediastinal anatomy'",
"    </a>",
"    .) Most of the mediastinal nodes are in close approximation to the left innominate vein, the anterior surface of the trachea, circumference of the main bronchi, and inferior and to the left of the aortic arch [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The International Association for the Study of Lung Cancer (IASLC) proposed classifying mediastinal nodes into regional lymph node stations and zones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lymph node stations and zones include (",
"    <a class=\"graphic graphic_figure graphicRef73945 \" href=\"mobipreview.htm?19/28/19914\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Highest mediastinal nodes &ndash; Supraclavicular zone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Station 1 &ndash; Low cervical, supraclavicular, and sternal notch nodes",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Superior mediastinal nodes &ndash; Upper zone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Station 2 &ndash; Upper paratracheal",
"   </p>",
"   <p>",
"    Station 3 &ndash; Prevascular and retrotracheal",
"   </p>",
"   <p>",
"    Station 4 &ndash; Lower paratracheal",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aortic and para-aortic nodes &ndash; AP zone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Station 5 &ndash; Subaortic",
"   </p>",
"   <p>",
"    Station 6 &ndash; Para-aortic (ascending aorta or phrenic)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inferior mediastinal nodes &ndash; Subcarinal zone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Station 7 &ndash; Subcarinal",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inferior mediastinal nodes &ndash; Lower zone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Station 8 &ndash; Paraesophageal (below carina)",
"   </p>",
"   <p>",
"    Station 9 &ndash; Pulmonary ligament",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      N1 nodes &ndash;",
"      <span class=\"nowrap\">",
"       Hilar/interlobar",
"      </span>",
"      zone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Station 10 &ndash; Hilar",
"   </p>",
"   <p>",
"    Station 11 &ndash; Interlobar",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      N1 nodes &ndash; Peripheral zone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Station 12 &ndash; Lobar",
"   </p>",
"   <p>",
"    Station 13 &ndash; Segmental",
"   </p>",
"   <p>",
"    Station 14 &ndash; Subsegmental",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H548647104\">",
"    <span class=\"h1\">",
"     SELECTION OF BIOPSY PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selection of the biopsy procedure depends on the stations of adenopathy and a history of prior neck and mediastinal surgical procedures. The procedure options include cervical mediastinoscopy, thoracoscopy, anterior mediastinotomy, endobronchial ultrasound, navigational bronchoscopy, and esophageal ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Mediastinoscopy",
"      </strong>",
"      &ndash; Mediastinoscopy can be performed as video assisted or direct optic visualization, and is used to biopsy lymph nodes upper paratracheal (stations 2R, 2L), right paratracheal (station 4R), and left paratracheal superior to the aortic arch (station 4L). The anterior subcarinal (station 7) and bilateral hilar nodes (stations 10R, 10L) may be accessible but are technically challenging (",
"      <a class=\"graphic graphic_figure graphicRef73945 \" href=\"mobipreview.htm?19/28/19914\">",
"       figure 3",
"      </a>",
"      ). The nodes can be sampled or removed entirely for histologic evaluation.",
"      <br/>",
"      <br/>",
"      The goal of mediastinoscopy for staging lung carcinoma patients is to obtain samples of all accessible lymph node stations: 2L, 2R, 4L, 4R, and 7. Microscopic lymph node metastasis can occur even in lymph nodes that appear grossly normal. A retrospective review of 215 patients undergoing mediastinal lymphadenectomy found that the incidence of occult N2 disease found at resection to be 16 percent for patients who were",
"      <span class=\"nowrap\">",
"       N2/N3",
"      </span>",
"      node negative by integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/6\">",
"       6",
"      </a>",
"      ]. Patients with metastases in lymph node stations contralateral to the lung tumor are upstaged to N3 disease rather than N2 ipsilateral mediastinal lymph nodes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44373?source=see_link&amp;anchor=H2#H2\">",
"       \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\", section on 'TNM staging'",
"      </a>",
"      .) For patients with diseases other than lung carcinoma, the authors limit the lymph node stations biopsied to those that are abnormal by radiographic evaluation.",
"      <br/>",
"      <br/>",
"      The authors prefer video assisted mediastinoscopy because of the optical magnification provided by the video mediastinoscope and the improved ability for the surgeon's assistant to view the operative field. Optical magnification allows for safer dissection and efficient identification of critical neurovascular structures.",
"      <br/>",
"      <br/>",
"      Prior lower neck surgery, particularly thyroid or parathyroid procedures, can create adhesions, which may obliterate the pretracheal space in the neck. The pretracheal space is generally not disturbed caudally by most neck procedures and a cervical mediastinoscopy can be safely performed. However, in the clinical setting of a previous mediastinoscopy, the pretracheal space may contain dense adhesions. In this setting, the authors prefer to perform an endobronchial ultrasound with transbronchial fine needle aspiration biopsy. Because the pretracheal space is not opened during routine median sternotomy, prior sternotomy should not affect the ability to perform a cervical mediastinoscopy.",
"     </li>",
"     <li>",
"      <strong>",
"       Thoracoscopy",
"      </strong>",
"      &ndash; Video-assisted thoracic surgery (VATS) is preferred by the authors to biopsy subaortic (station 5) and para-aortic (station 6) nodes. If the nodes are large and extend to the anterior chest wall, the authors prefer an anterior mediastinotomy. Thoracoscopy also allows the surgeon a much broader field of vision and the ability to rule out pleural dissemination. It also provides the ability to biopsy paratracheal (station 2), azygos (station 4R), paraesophageal (station 8), or pulmonary ligament (station 9) lymph nodes (",
"      <a class=\"graphic graphic_figure graphicRef73945 \" href=\"mobipreview.htm?19/28/19914\">",
"       figure 3",
"      </a>",
"      ). The nodes can be sampled or removed entirely for histologic evaluation. The authors biopsy lymph node stations identified on preoperative imaging as abnormal before proceeding to biopsy any other lymph nodes present.",
"     </li>",
"     <li>",
"      <strong>",
"       Anterior mediastinotomy",
"      </strong>",
"      &ndash; An anterior mediastinotomy (Chamberlain procedure), is performed to biopsy left paratracheal (station 4L), para-aortic (station 6), subaortic (station 5), and subcarinal nodes (station 7) as well as to biopsy an anterior mediastinal mass. The nodes can be sampled or removed entirely for histologic evaluation.",
"     </li>",
"     <li>",
"      <strong>",
"       Endobronchial ultrasound",
"      </strong>",
"      &ndash; Endobronchial ultrasound can be performed to biopsy lymph nodes in stations 1-4, 7, and 10&ndash;12 (",
"      <a class=\"graphic graphic_figure graphicRef73945 \" href=\"mobipreview.htm?19/28/19914\">",
"       figure 3",
"      </a>",
"      ). The nodes are biopsied by a fine needle aspiration (FNA) approach through the trachea or bronchus (",
"      <a class=\"graphic graphic_figure graphicRef63771 \" href=\"mobipreview.htm?0/10/167\">",
"       figure 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/16/12552?source=see_link\">",
"       \"Endoscopic ultrasound-guided fine-needle aspiration in the mediastinum\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Esophageal ultrasound",
"      </strong>",
"      &ndash; Esophageal ultrasound is performed to biopsy subcarinal (station 7), paraesophageal (station 8), and pulmonary ligament (station 9) nodes. The biopsy is performed as a FNA. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/36/27208?source=see_link&amp;anchor=H7#H7\">",
"       \"Endoscopic ultrasound in esophageal carcinoma\", section on 'EUS for preoperative lymph node staging'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H412303\">",
"    <span class=\"h1\">",
"     TECHNICAL APPROACHES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The technical approaches for a cervical mediastinoscopy, anterior mediastinotomy, and thoracoscopy are discussed here. The technical approaches to endoscopy are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/26/43427?source=see_link\">",
"     \"Endobronchial ultrasound: Technical aspects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/9/12442?source=see_link&amp;anchor=H67011548#H67011548\">",
"     \"Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)\", section on 'Technique'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H104363538\">",
"    <span class=\"h2\">",
"     Preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical mediastinoscopy, anterior mediastinotomy, and thoracoscopy are generally performed as outpatient operations under a general anesthetic, although thoracoscopy is a more extensive procedure requiring thoracostomy tube placement and typically an overnight admission.",
"   </p>",
"   <p>",
"    Antibiotic prophylaxis is typically administered intravenously, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/61/26583?source=see_link\">",
"     cefuroxime",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (",
"    <a class=\"graphic graphic_table graphicRef87205 \" href=\"mobipreview.htm?26/48/27404\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link&amp;anchor=H15#H15\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'Noncardiac thoracic surgery'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    In preparation for a cervical mediastinoscopy or anterior mediastinotomy, the patient is positioned supine, with a shoulder roll placed under the scapulae and the neck extended. Oxygen saturation is monitored by a right extremity pulse oximeter or a right radial arterial line that can also serve as an indirect assessment of brachiocephalic arterial compression. Because of the risk of embolization caused by innominate artery compression during mediastinoscopy, the authors consider a calcified innominate artery to be a contraindication to mediastinoscopy. &nbsp;",
"   </p>",
"   <p>",
"    Vaginal gauze packing strips should be on the sterile field at all times. A median sternotomy saw and instruments should be in the operating room during all mediastinoscopies, since median sternotomy is the preferred approach to control major bleeding from the innominate artery, aortic arch, and right pulmonary artery.",
"   </p>",
"   <p>",
"    In preparation for a thoracoscopy, single lung ventilation is performed via a double lumen endotracheal tube or a bronchial blocker, depending on the anesthesiologist and surgeon&rsquo;s preference. The patient is placed in the lateral decubitus position and secured in place with tape",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a sandbag. The operating room table is flexed to prevent the hip from interfering with the instruments and camera, as well as to open the intercostal spaces.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H104363558\">",
"    <span class=\"h2\">",
"     Gross appearance of nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal and inflammatory lymph nodes in the mediastinum are rubbery and pearly white to gray; those affected by anthracosis are typically grayish-black while those involved with metastatic disease from the lung or other solid tumors are hard, and often have a whitish appearance. The gross appearance of a lymphomatous node is gray and firm, though often not hard. Granulomatous lymph nodes, as in sarcoidosis, are typically yellow in color and hard. If there is doubt as to the nature of a given structure, an aspiration with a 22-gauge needle should be performed prior to a biopsy. A bloodless aspirate is not confirmation that the structure is not a vessel. Matted nodes may be densely adherent to blood vessels. Simple excision of normal-appearing fat is unlikely to yield concealed lymph nodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H548647111\">",
"    <span class=\"h2\">",
"     Mediastinoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A midline transverse incision is made immediately above the clavicular heads. The incision is carried through the platysma, between the strap muscles (sternothyroid, sternohyoid, thyrohyoid, and omohyoid muscles), and down to the anterior surface of the trachea, where the pretracheal plane is entered. Once this plane is identified, blunt finger or direct video dissection is used to develop this plane distally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Small blood vessels that disrupt the course of dissection can be secured with 5 mm laparoscopic hemostatic clips or electrocauterized. Extreme caution must be exercised when using cautery in the mediastinum and major structures, such as the recurrent laryngeal nerve, trachea, and great vessels, and the barrel of the mediastinoscope and other instruments, must be avoided. Mediastinoscopy biopsy forceps are used to sample the nodal tissue or remove small, intact nodes.",
"   </p>",
"   <p>",
"    The strap muscles and the platysma are closed using serial layers of absorbable suture prior to skin closure, to avoid adherence of the trachea directly to the skin and in case the patient requires a future cervical incision.",
"   </p>",
"   <p>",
"    In our institution, we proceed with a resection of a lung cancer in the same setting as the mediastinoscopy if the frozen section of N2 and N3 nodes is negative for metastatic disease. In situations of equivocal frozen section results or for disease other than lung cancer, the surgeon and pathologist must be satisfied with the amount of tissue sampled, and the surgeon may prefer to wait for permanent results prior to performing a pulmonary resection. A retrospective study of 122 patients with bronchogenic carcinoma who underwent cervical mediastinoscopy reported a false negative rate of 1.6 percent, sensitivity of 94.6 percent, and a specificity of 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H412278\">",
"    <span class=\"h2\">",
"     Anterior mediastinotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A transverse incision is made immediately lateral and to the left of the sternum at the angle of Louie, along the second costal cartilage. The laterality and cartilage chosen may vary if an anterior mediastinal mass is being biopsied, depending on the entry point that will allow the best access to the tumor. The incision is carried between the pectoralis fibers down to the second costal cartilage, which is incised along its midpoint from the sternum to the costochondral junction. The perichondrium is dissected circumferentially from the costal cartilage using a periosteal elevator, and the costal cartilage is excised flush with the sternum medially and at the costochondral junction laterally. The internal mammary artery is swept laterally and the mediastinum is entered medially; this technique minimizes the chances of entering the pleura and causing a pneumothorax.",
"   </p>",
"   <p>",
"    After identifying the node or tumor, biopsies are performed by grasping a portion of the mass and excising it with scissors or a scalpel. Alternatively, mediastinoscopy biopsy forceps can be used to obtain specimen.",
"   </p>",
"   <p>",
"    The perichondrium can be closed at the surgeon&rsquo;s discretion and the muscle and subcutaneous tissues are reapproximated. If the pleura has been entered, as evidenced by air bubbles emerging when irrigation is placed into the wound, a red robin catheter is placed through the wound into the mediastinum and attached to suction as the wound is closed around it. When the running subcutaneous layer is completed, it is left untied. The catheter is then removed while the suture is tightened, preventing air from reentering the chest. The suture is tied and the skin is closed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H412844\">",
"    <span class=\"h2\">",
"     Thoracoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An incision for the port for the thoracoscope is typically placed in the anterior axillary line near the diaphragm. A utility incision is made in the third, fourth, or fifth interspace, and in the anterior axillary line. An additional working port may be created below the inframammary crease medially to facilitate exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Biopsy of the 2R and 4R lymph node stations requires that the overlying mediastinal pleura be carefully incised lateral to the right phrenic nerve to avoid injuring the nerve. The left recurrent laryngeal nerve must be visualized and preserved when performing a biopsy of levels 5 and 6 lymph nodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H548647118\">",
"    <span class=\"h1\">",
"     COMPLICATIONS OF MEDIASTINOSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the close proximity of the mediastinal nodes to major blood vessels and critical structures, intra-operative complications such as life-threatening hemorrhage and tracheal tear can occur. The most commonly injured blood vessels that require a median sternotomy for definitive control include the azygous vein, pulmonary artery, and innominate artery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/10\">",
"     10",
"    </a>",
"    ]. Injury to the recurrent laryngeal nerve produces vocal cord palsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The morbidity and mortality of a mediastinoscopy is relatively low. A single institutional review of a nine-year experience of 2145 patients undergoing a mediastinoscopy found that the overall morbidity and mortality of the procedure was 1.07 percent and 0.05 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/12\">",
"     12",
"    </a>",
"    ]. The most frequent complications included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent laryngeal nerve injury &ndash; 12 patients (0.55 percent)",
"     </li>",
"     <li>",
"      Hemorrhage &ndash; 7 patients (0.33 percent)",
"     </li>",
"     <li>",
"      Tracheal injury &ndash; 2 patients (0.09 percent)",
"     </li>",
"     <li>",
"      Pneumothorax &ndash; 2 patients (0.09 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of the seven patients who experienced hemorrhage, five were the result of a biopsy of lower paratracheal nodes (station 4), and one death resulted from injury to the pulmonary artery. Another retrospective review identified a comparable low morbidity rate (2.9 percent) and no mortality for 34 consecutive patients undergoing a mediastinoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Injury to the esophagus is extremely rare. With the mediastinoscope anterior to the trachea, the esophagus is protected; however, an anterior wall perforation can occur with overly aggressive biopsy of the subcarinal lymph node station [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H104363723\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The great vessels (eg, innominate vein, pulmonary arteries, azygous vein), trachea, esophagus, and recurrent laryngeal nerves must be identified during mediastinoscopy to avoid injury. The best preventive methods include clear identification of the node to be biopsied and its relationship to the adjacent structures, plus meticulous biopsy technique.",
"   </p>",
"   <p>",
"    The following nodal stations and structures require particular attention during dissection (",
"    <a class=\"graphic graphic_figure graphicRef73945 \" href=\"mobipreview.htm?19/28/19914\">",
"     figure 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Upper and lower paratracheal nodes (stations 2 and 4)",
"      </strong>",
"      &ndash; Structures that can be damaged during the initial pretracheal dissection and biopsy of the upper paratracheal nodes include the aorta, the innominate vein, superior vena cava, and the trachea. The aortic arch crosses the trachea transversely, and the innominate artery arises from the left side of the aortic arch and crosses the trachea obliquely to the right. The superior vena cava, which lies on the right anterior surface of the lower trachea, should be identified and protected during right paratracheal dissection, as well as the azygous vein, which travels from anterior to posterior on the right side of the lower trachea.",
"      <br/>",
"      <br/>",
"      The left recurrent laryngeal nerve, located lateral and parallel to the trachea, is in close approximation to the paratracheal nodes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/15\">",
"       15",
"      </a>",
"      ]. The nerve must be identified and preserved prior to performing an upper or lower paraesophageal node biopsy.",
"     </li>",
"     <li>",
"      <strong>",
"       Para-aortic lymph nodes (station 5)",
"      </strong>",
"      &ndash; The right pulmonary artery (PA) passes transversely over the distal tracheal and subcarinal area.",
"      <strong>",
"      </strong>",
"      Overly aggressive traction on lymph nodes in this area can damage the PA, which is thin-walled and fragile.",
"     </li>",
"     <li>",
"      <strong>",
"       Subcarinal and paraesophageal lymph nodes (stations 7 and 8)",
"      </strong>",
"      &ndash; The esophagus lies immediately posterior to the subcarinal lymph nodes (station 7) and between the paraesophageal nodes (station 8), and is at risk for injury or perforation. The biopsy should clearly contain only nodal tissue; the presence of skeletal or smooth muscle should alert the surgeon to possible esophageal injury, which should prompt an esophagoscopy if recognition occurs in the operating room while the patient is still anesthetized. Otherwise, a contrast esophagram should be performed. &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Hilar lymph nodes (station 10R)",
"      </strong>",
"      &ndash; This lymph node station is not routinely biopsied by most thoracic surgeons. The anterior trunk of the right PA is often encountered during dissection of the right hilar (tracheobronchial angle, station 10R) nodes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H104363715\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H104363666\">",
"    <span class=\"h3\">",
"     Life-threatening hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first maneuver to control hemorrhage is to pack vaginal gauze strips through the mediastinoscope in an attempt to tamponade the bleeding. The surgeon should not remove the mediastinoscope from the pretracheal space, as this may displace the packing, and prevent the surgeon from identifying the source of bleeding again [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If packing achieves hemostasis, the packing is left in place for a minimum of 10 to 30 minutes. The packing is gently removed and the site is reinspected for bleeding. If large amounts of bleeding persist, the packing is replaced and the process repeated. However, if bleeding persists despite multiple attempts at packing, or if the bleeding overwhelms attempts at packing, the surgeon must obtain definitive control of bleeding, typically by median sternotomy. If the patient is stable and can be repositioned, a right thoracotomy may provide superior exposure for controlling hemorrhage from the azygous vein, posterior superior vena cava, or segmental pulmonary artery injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following the median sternotomy or right thoracotomy and effective control of hemorrhage, the definitive resection of the pulmonary lesion may be performed if the patient is hemodynamically stable and the mediastinal lymph nodes are negative for metastatic disease by frozen section analysis. However, a left lower lobectomy is challenging through a median sternotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H104363674\">",
"    <span class=\"h3\">",
"     Tracheal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheal injuries can occur during the insertion of the mediastinoscope or dissection. Proximal tracheal tears typically occur during the initial dissection and entry into the pretracheal plane. They are confirmed by submerging the exposed trachea under water and observing for air bubbles.",
"   </p>",
"   <p>",
"    If the tracheobronchial tree is injured within the mediastinum, the mediastinal space is contaminated. Depending on the extent of the injury, open repair of the trachea is indicated, as well as drainage of the mediastinum. If the injury to the trachea is at the entry point of the mediastinoscope, then the repair is performed through the original incision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tracheal injuries are closed with absorbable suture (classically simple, interrupted Vicryl sutures), tying tightly enough to create an airtight closure, but not tearing the tracheal cartilages. Leaving a Blake or Jackson-Pratt drain over the tracheal repair within the pretracheal space allows the surgeon to confirm that the tracheal repair remains airtight on postoperative day one, as shown by the drain retaining bulb suction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H160401636\">",
"    <span class=\"h3\">",
"     Esophageal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;If there is any question regarding a potential esophageal injury, an immediate esophagoscopy is performed. If negative, a contrast esophagram should be performed. The management of an iatrogenic esophageal perforation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/20/329?source=see_link&amp;anchor=H3823291#H3823291\">",
"     \"Surgical management of esophageal perforation\", section on 'Principles of surgical management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H160401784\">",
"    <span class=\"h3\">",
"     Pneumothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many surgeons obtain a postoperative chest radiograph routinely. A small violation of the mediastinal pleura may cause a pneumothorax that will resolve with time. If a pneumothorax is recognized intra-operatively, the surgeon may insert a suction catheter into the defect and aspirate the air prior to final skin closure. In contrast, a pneumothorax that occurs due to a lung parenchymal injury is more likely to be associated with increased peak inspiratory pressures, tracheal shift, distant breath sounds, hypotension, and cyanosis. Such signs are indicators that a closed tube thoracostomy is required for immediate decompression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/12/1226?source=see_link\">",
"     \"Placement and management of thoracostomy tubes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H160401805\">",
"    <span class=\"h3\">",
"     Recurrent laryngeal nerve injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;An injury to the recurrent laryngeal nerve (RLN) is typically diagnosed postoperatively by the symptoms of new, unresolving hoarseness, dysphonia, limited phonation time, or vocal fatigue (",
"    <a class=\"graphic graphic_figure graphicRef82397 \" href=\"mobipreview.htm?40/57/41878\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef61802 \" href=\"mobipreview.htm?22/40/23177\">",
"     figure 6",
"    </a>",
"    ). The most common type of RLN injury following a mediastinoscopy is unilateral [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44310?source=see_link&amp;anchor=H15#H15\">",
"     \"Surgical anatomy of the thyroid gland\", section on 'Recurrent laryngeal nerve'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/40/16009?source=see_link&amp;anchor=H22#H22\">",
"     \"Hoarseness in adults\", section on 'Neurologic dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No treatment is required for unilateral vocal cord palsy after mediastinoscopy, as it will spontaneously resolve in at least 50 percent of patients within one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/18\">",
"     18",
"    </a>",
"    ]. In the setting of a permanent vocal cord injury, the planned resection of the pulmonary lesion should be performed prior to a thyroplasty to avoid damaging a vocal cord repair by a double lumen endotracheal tube required for the thoracic procedure. Prior to resection, the patient with permanent vocal cord injury should undergo vocal cord injection to prevent aspiration post pulmonary resection. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H548647181\">",
"    <span class=\"h1\">",
"     COMPLICATIONS OF ANTERIOR MEDIASTINOTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anterior mediastinotomy is a more invasive procedure than mediastinoscopy, and hence carries a higher risk of morbidity and mortality compared with mediastinoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/19\">",
"     19",
"    </a>",
"    ]. In a retrospective review of 117 consecutive patients undergoing an anterior mediastinotomy, the morbidity rate was 6.8 percent and there was no mortality attributed to the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/13\">",
"     13",
"    </a>",
"    ]. Intra-operative complications included hemorrhage (n = 1), pneumothorax (n = 1), injury to the recurrent laryngeal nerve (n = 1), and hypoxia (n = 2). Injury to the internal mammary artery",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    aorta, while uncommon, can result in life-threatening hemorrhage.",
"   </p>",
"   <p>",
"    The authors routinely obtain a postoperative chest radiograph to assess for a pneumothorax. A symptomatic pneumothorax is treated with a thoracostomy tube. Those that are not symptomatic are treated expectantly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H160402423\">",
"    <span class=\"h1\">",
"     COMPLICATIONS OF THORACOSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Massive bleeding from an artery or vein is an uncommon but life-threatening complication of thoracoscopy. Conversion from a thoracoscopic (VATS) procedure to an open thoracotomy occurs in as many as 22 percent of procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/9\">",
"     9",
"    </a>",
"    ]. Other possible complications include chylothorax, pneumothorax, phrenic nerve injury, left recurrent laryngeal nerve injury, and esophageal perforation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32183/abstract/8\">",
"     8",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    These possible complications highlight the fact that with thoracoscopy, as with all new technology and skill sets, education, practice, and a learning curve necessarily accompany performance of the procedure. Management of hemorrhage and other possible injuries are reviewed separately. (See",
"    <a class=\"local\" href=\"#H104363715\">",
"     'Management'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H90093901\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of mediastinal nodes is paramount for staging patients with suspected or proven bronchogenic carcinomas, and for diagnosing primary and secondary malignancies involving mediastinal lymph nodes.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mediastinoscopy can be performed as video-assisted or direct optic visualization, and is used to biopsy lymph nodes upper paratracheal (stations 2R, 2L), right paratracheal (station 4R), and left paratracheal superior to the aortic arch (station 4L). (See",
"      <a class=\"local\" href=\"#H548647104\">",
"       'Selection of biopsy procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thoracoscopy is used to biopsy subaortic (station 5) and para-aortic (station 6) nodes. If the nodes are large and extend to the anterior chest wall, the authors prefer an anterior mediastinotomy. Thoracoscopy can also be performed to biopsy azygos (station 4R), paraesophageal (station 8), or pulmonary ligament (station 9) lymph nodes. (See",
"      <a class=\"local\" href=\"#H548647104\">",
"       'Selection of biopsy procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An anterior mediastinotomy (Chamberlain procedure), is performed to biopsy left paratracheal (station 4L), para-aortic (station 6), subaortic (station 5), and subcarinal nodes (station 7) as well as to biopsy an anterior mediastinal mass. (See",
"      <a class=\"local\" href=\"#H548647104\">",
"       'Selection of biopsy procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major risks and complications of mediastinoscopy and biopsy include life-threatening hemorrhage, and injury to the trachea, esophagus, and recurrent laryngeal nerve. (See",
"      <a class=\"local\" href=\"#H548647118\">",
"       'Complications of mediastinoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A median sternotomy should be performed to control hemorrhage resulting from a mediastinoscopy if packing with vaginal gauze strips through the mediastinoscope is not effective. (See",
"      <a class=\"local\" href=\"#H104363666\">",
"       'Life-threatening hemorrhage'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/1\">",
"      Genereux GP, Howie JL. Normal mediastinal lymph node size and number: CT and anatomic study. AJR Am J Roentgenol 1984; 142:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/2\">",
"      Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4:568.",
"     </a>",
"    </li>",
"    <li>",
"     Section 7. Thorax. In: Gray's Anatomy: The anatomical basis of clinical practice, Fortieth, Standring S..  (Ed), Churchill, Livingstone, Elsevier, London, UK 2008. p.909.",
"    </li>",
"    <li>",
"     Smithuis R. Lung cancer lymph node map - Update. file://www.radiologyassistant.nl/en/4646f1278c26f (Accessed on October 31, 2011).",
"    </li>",
"    <li>",
"     Chapter 20. Video-Assisted Mediastinoscopy. In: Atlas of Minimally Invasive Thoracic Surgery, First, McKenna RJ, Mahtabifard A, Swanson SJ, Saunders, Philadelphia, PA 2010. p.203-212.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/6\">",
"      Al-Sarraf N, Aziz R, Gately K, et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg 2008; 33:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/7\">",
"      Gephardt GN, Rice TW. Utility of frozen-section evaluation of lymph nodes in the staging of bronchogenic carcinoma at mediastinoscopy and thoracotomy. J Thorac Cardiovasc Surg 1990; 100:853.",
"     </a>",
"    </li>",
"    <li>",
"     Chapter 21. Right-Sided Mediastinal Lymph Node Dissection. In: Atlas of Minimally Invasive Thoracic Surgery, First, McKenna RJ, Mahtabifard A, Swanson SJ, Saunders, Philadelphia, PA 2010. p.213.",
"    </li>",
"    <li>",
"     Rau B, Hunerbein M, Below C, Schlag PM: Video-assisted thoracic surgery: Staging and management of thoracic tumors. Surg Endosc 1998;12:133.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/10\">",
"      Park BJ, Flores R, Downey RJ, et al. Management of major hemorrhage during mediastinoscopy. J Thorac Cardiovasc Surg 2003; 126:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/11\">",
"      Roberts JR, Wadsworth J. Recurrent laryngeal nerve monitoring during mediastinoscopy: predictors of injury. Ann Thorac Surg 2007; 83:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/12\">",
"      Lemaire A, Nikolic I, Petersen T, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg 2006; 82:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/13\">",
"      Nechala P, Graham AJ, McFadden SD, et al. Retrospective analysis of the clinical performance of anterior mediastinotomy. Ann Thorac Surg 2006; 82:2004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/14\">",
"      Dernevik L, Larsson S, Pettersson G. Esophageal perforation during mediastinoscopy--the successful management of 2 complicated cases. Thorac Cardiovasc Surg 1985; 33:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/15\">",
"      Benouaich V, Marcheix B, Carfagna L, et al. Anatomical bases of left recurrent nerve lesions during mediastinoscopy. Surg Radiol Anat 2009; 31:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/16\">",
"      Angelillo-Mackinlay T. Transcervical repair of distal membranous tracheal laceration. Ann Thorac Surg 1995; 59:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/17\">",
"      Rubin AD, Sataloff RT. Vocal fold paresis and paralysis. Otolaryngol Clin North Am 2007; 40:1109.",
"     </a>",
"    </li>",
"    <li>",
"     Slinger, PD, Campos, JH. Anesthesia for thoracic surgery. In: Miller's Anesthesia, Miller, RD (Eds), Churchill Livingstone, 2009. p.1855.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32183/abstract/19\">",
"      Valli&egrave;res E, Pag&eacute; A, Verdant A. Ambulatory mediastinoscopy and anterior mediastinotomy. Ann Thorac Surg 1991; 52:1122.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15135 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-77.94.48.4-442DE206A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32183=[""].join("\n");
var outline_f31_27_32183=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H90093901\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H548647065\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H548647079\">",
"      CLASSIFICATION MEDIASTINAL LYMPH NODES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H548647104\">",
"      SELECTION OF BIOPSY PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H412303\">",
"      TECHNICAL APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H104363538\">",
"      Preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H104363558\">",
"      Gross appearance of nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H548647111\">",
"      Mediastinoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H412278\">",
"      Anterior mediastinotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H412844\">",
"      Thoracoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H548647118\">",
"      COMPLICATIONS OF MEDIASTINOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H104363723\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H104363715\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H104363666\">",
"      - Life-threatening hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H104363674\">",
"      - Tracheal injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H160401636\">",
"      - Esophageal injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H160401784\">",
"      - Pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H160401805\">",
"      - Recurrent laryngeal nerve injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H548647181\">",
"      COMPLICATIONS OF ANTERIOR MEDIASTINOTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H160402423\">",
"      COMPLICATIONS OF THORACOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H90093901\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15135\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15135|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/32/17923\" title=\"figure 1\">",
"      Thoracic lymph nodes - Anterior view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/38/14948\" title=\"figure 2\">",
"      Thoracic lymph nodes - Posterior view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/28/19914\" title=\"figure 3\">",
"      IASLC lymph node map",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/10/167\" title=\"figure 4\">",
"      Mediastinal LN approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/57/41878\" title=\"figure 5\">",
"      Thyroid nerves normal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?22/40/23177\" title=\"figure 6\">",
"      Thyroid nerves variants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15135|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/48/27404\" title=\"table 1\">",
"      Antimicrobial prophylaxis for thoracic non-cardiac surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/40/32392?source=related_link\">",
"      Anterior mediastinal mass lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/26/43427?source=related_link\">",
"      Endobronchial ultrasound: Technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/36/27208?source=related_link\">",
"      Endoscopic ultrasound in esophageal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/16/12552?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration in the mediastinum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/24/31111?source=related_link\">",
"      Evaluation of mediastinal masses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/40/16009?source=related_link\">",
"      Hoarseness in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/9/12442?source=related_link\">",
"      Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=related_link\">",
"      Pathology of mediastinal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/12/1226?source=related_link\">",
"      Placement and management of thoracostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44310?source=related_link\">",
"      Surgical anatomy of the thyroid gland",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/20/329?source=related_link\">",
"      Surgical management of esophageal perforation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44373?source=related_link\">",
"      Tumor node metastasis (TNM) staging system for non-small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_27_32184="Anatomy and innervation of the diaphragm";
var content_f31_27_32184=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F64543&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F64543&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 574px\">",
"   <div class=\"ttl\">",
"    Anatomy and innervation of the diaphragm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 554px; height: 612px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) The diaphragm is dome-shaped and attaches to the chest and abdominal walls circumferentially. The diaphragm is composed of two muscle groups, costal and crural. The costal muscle group forms the diaphragmatic leaflets. The right and left crus of the diaphragm are thick but contribute minimally to the displacement of the diaphragm. The median arcuate ligament anterior to the aortic hiatus is formed by the continuation of the medial tendinous margins of the crura. The costal and crural fibers insert into the central tendon. The anterior portion of the central tendon attaches to the posterior aspect of the xiphisternal junction. The posterior portion of the central tendon attaches to L1 to L3.",
"    <br>",
"     (B) The phrenic nerve originates in the neck and traverses the mediastinum before inserting into the diaphragm centrally. The outer rim of the diaphragmatic muscle is innervated laterally from the T7 through T12. The crural group of muscles receive innervation from the vagus nerve.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Adapted and reproduced with permission from:",
"      <br>",
"       (A) Anderson JE. Grant's Atlas of Anatomy, 7th Edition. Baltimore, Williams &amp; Wilkins Co., 1978. Copyright &copy; 1978 Lippincott Williams &amp; Wilkins.",
"       <br>",
"        (B) Moore KL, Dalley AF. Clinically Oriented Anatomy, 4th Edition. Baltimore, Lippincott Williams &amp; Wilkins, 1999. Copyright &copy; 1999 Lippincott Williams &amp; Wilkins.",
"       </br>",
"      </br>",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32184=[""].join("\n");
var outline_f31_27_32184=null;
var title_f31_27_32185="Diagnostic approach to and treatment of goiter in adults";
var content_f31_27_32185=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic approach to and treatment of goiter in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/27/32185/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32185/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/27/32185/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32185/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/27/32185/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/27/32185/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/27/32185/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Goiter refers to abnormal growth of the thyroid gland. Adults may have goiters that are diffuse or nodular, and the goiters may be associated with normal, decreased, or increased thyroid hormone production. The approach to the patient with goiter and the treatment of nonobstructive, nontoxic goiter will be reviewed here. Obstructive or substernal goiter and toxic multinodular goiter are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"     \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32742?source=see_link\">",
"     \"Treatment of obstructive or substernal goiter\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/30/41448?source=see_link\">",
"     \"Treatment of toxic adenoma and toxic multinodular goiter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289320\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iodine deficiency is the most common cause of goiter worldwide. In mildly and moderately iodine-deficient regions in Denmark, goiter (as determined by ultrasonography) is present in 15 and 22.6 percent of the population, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/59/39864?source=see_link&amp;anchor=H3#H3\">",
"     \"Iodine deficiency disorders\", section on 'Diffuse and nodular goiter'",
"    </a>",
"    .) In the United States, where significant iodine deficiency does not exist, multinodular goiter, chronic autoimmune (Hashimoto&rsquo;s) thyroiditis, and Graves&rsquo; disease are more common causes of goiter. In the elderly, multinodular goiter is most common.",
"   </p>",
"   <p>",
"    Other less common causes of goiter include tumors, thyroiditis, and infiltrative diseases (",
"    <a class=\"graphic graphic_table graphicRef67399 \" href=\"mobipreview.htm?16/53/17244\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43830?source=see_link\">",
"     \"Overview of thyroiditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/15/43257?source=see_link\">",
"     \"Infiltrative thyroid disease\"",
"    </a>",
"    .) The risk of thyroid cancer within a multinodular goiter is approximately 3 to 5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/2\">",
"     2",
"    </a>",
"    ], similar to the risk in a solitary thyroid nodule. In a series of 718 patients operated on for goiter in Pakistan, 2.92 percent of patients were found to have a malignancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10798374\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with iodine deficiency or chronic autoimmune (Hashimoto's) thyroiditis, an increase in thyroid stimulating hormone (TSH) secretion is the predominant cause of goiter. In contrast, most patients with sporadic nontoxic multinodular goiters have normal serum TSH concentrations. In them, the thyroid enlargement is probably caused by several growth factors (including TSH) that act over time on thyroid follicular cells that have different synthetic and growth potentials. There is often a family history of goiter, suggesting that genetic factors may also play a role. The result is diffuse and later multinodular thyroid enlargement. Some nodules eventually become autonomous due to activating mutations in the TSH receptor or G proteins within the thyroid follicular cells. The following observations support this sequence of events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thyroid volume is larger in older patients.",
"     </li>",
"     <li>",
"      The longer the patient has a goiter, the larger the size of the goiter.",
"     </li>",
"     <li>",
"      The larger the size of the goiter, the lower the serum TSH concentration.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with Graves&rsquo; disease, thyrotropin receptor antibodies stimulate the TSH receptor to cause thyroid growth and excessive hormonal secretion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/30/40425?source=see_link\">",
"     \"Pathogenesis of Graves' disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289328\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of a goiter is usually made at the time of a physical examination. Goiter may also be an incidental finding during a radiologic procedure performed for other purposes (eg, carotid ultrasound).",
"   </p>",
"   <p>",
"    Once goiter is detected, the diagnostic evaluation is aimed at identifying the underlying cause, the presence of obstructive symptoms, the presence of suspicious sonographic features in nodules within the goiter, and assessing thyroid function. These factors will determine management. It is important to rule out malignancy through history, clinical examination, ultrasound, and fine needle aspiration biopsy of large or suspicious nodules. In the absence of autoimmune thyroid disease, thyroiditis, and thyroid malignancy, benign multinodular goiter is the most likely diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289353\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of goiter depend upon the presence of thyroid dysfunction and upon the size and growth rate of the goiter. Some patients may have symptoms of hypothyroidism or hyperthyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14503?source=see_link\">",
"     \"Clinical manifestations of hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    .) Most goiters grow very slowly over many decades. Therefore, the majority of patients with goiter are asymptomatic.",
"   </p>",
"   <p>",
"    Differentiated thyroid cancers grow slowly and may be indistinguishable clinically from a uninodular or multinodular benign goiter. The rare anaplastic thyroid cancers or primary lymphomas of the thyroid often present with a rapidly enlarging neck mass that may cause obstructive symptoms, such as dyspnea, wheezing, and cough. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/10/23721?source=see_link\">",
"     \"Anaplastic thyroid cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/8/35974?source=see_link\">",
"     \"Thyroid lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with long-standing goiters may also develop symptoms of obstruction, due to progressive compression of the trachea or sudden enlargement (usually accompanied by pain) secondary to hemorrhage into a nodule. The evaluation of a patient with obstructive symptoms is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"     \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rapid thyroid growth also occurs in patients with infectious (suppurative) or subacute thyroiditis. However, the growth is typically accompanied by pain and fever. In patients with infection, the thyroid abnormalities are predominantly unilateral, whereas most patients with subacute thyroiditis have bilateral thyroid enlargement and pain. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43830?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of thyroiditis\", section on 'Infectious thyroiditis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/23/1399?source=see_link\">",
"     \"Subacute thyroiditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We prefer to palpate the thyroid from the front of the patient so that landmarks such as the cricoid cartilage and sternocleidomastoid muscles are visible. The isthmus is located just below the cricoid. Thumbs or fingers are placed obliquely between the sternocleidomastoid and the trachea, compressing thyroid tissue on the tracheal surface. It is helpful to have the patient swallow a sip of water during palpation, allowing the examiner to feel the upward movement of the thyroid gland. The neck should be palpated to assess the size of the thyroid gland, for the presence of firm or dominant nodules, and for cervical adenopathy. The presence of a thyroid bruit (a sign of increased blood flow) may indicate hyperthyroidism. One or more discrete nodules may be palpable. However, the physical examination of goiter is highly inaccurate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/2,6,7\">",
"     2,6,7",
"    </a>",
"    ]. Glands that are diffuse on physical exam are often nodular by sonography, and most individuals with thyroid enlargement and a solitary palpable nodule on physical examination actually have multiple nodules when investigated by sonography.",
"   </p>",
"   <p>",
"    In patients with goiter, a history of iodine intake (including country of origin), medication history, family history of benign or malignant thyroid disease, and history of head and neck irradiation or radioiodine exposure from nuclear power plant accidents (Chernobyl, Fukushima) should be obtained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289336\">",
"    <span class=\"h2\">",
"     Diagnostic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation in patients with goiter (discovered either by palpation or incidentally noted on a radiologic procedure) is measurement of serum thyroid stimulating hormone (TSH). For patients with nontoxic goiter unrelated to Hashimoto&rsquo;s thyroiditis or iodine deficiency, a thyroid ultrasound should be obtained to assess sonographic features, the presence of nodularity, and the presence of lymphadenopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289413\">",
"    <span class=\"h3\">",
"     Thyroid function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum TSH should be measured in all patients with goiter. Patients with goiter may have normal thyroid function, hyperthyroidism (subclinical or overt), or hypothyroidism (subclinical or overt). If the TSH is below normal, serum free T4 and total T3 should also be measured. In patients with overt or subclinical hyperthyroidism and goiter, multinodular goiter with autonomy or Graves&rsquo; disease is the most likely diagnosis. If serum TSH is above normal, free T4 should be measured. Many thyroid experts also check serum thyroid peroxidase (TPO) antibodies. For patients with hypothyroidism and goiter living in the United States, Hashimoto&rsquo;s thyroiditis is most likely, and TPO antibodies will be elevated. In iodine deficient regions, iodine deficiency should be considered. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26520?source=see_link\">",
"     \"Diagnosis of hyperthyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/0/4103?source=see_link\">",
"     \"Disorders that cause hyperthyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26744?source=see_link\">",
"     \"Diagnosis of and screening for hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/47/42744?source=see_link\">",
"     \"Disorders that cause hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289421\">",
"    <span class=\"h3\">",
"     Thyroid ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid ultrasound should be obtained in all patients with nontoxic goiter unrelated to Hashimoto&rsquo;s thyroiditis or iodine deficiency. In the latter two circumstances, ultrasound should be reserved for patients with thyroid asymmetry or palpable nodules. Thyroid ultrasound in patients with Hashimoto&rsquo;s thyroiditis should be interpreted with caution due to the diffuse heterogeneity and the presence of pseudonodules related to ongoing inflammation.",
"   </p>",
"   <p>",
"    Ultrasound may identify distinctive, nonpalpable thyroid nodules within a nodular or diffuse goiter. Nodules with indeterminate or suspicious ultrasound features should be considered for biopsy because the prevalence of cancer in an individual nodule in a goiter is independent of the number of sonographically identified nodules. The evaluation and management of thyroid nodules are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28506?source=see_link\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ultrasound may be useful in evaluating a region of a goiter with unusual characteristics on palpation, such as hard consistency or tenderness, findings suggestive of possible coexisting cancer or lymphoma. The ultrasonic texture of a goiter and Doppler dynamics may yield information about diagnosis, function, and possibly even prognosis and medical management. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/62/21482?source=see_link&amp;anchor=H27#H27\">",
"     \"Overview of the clinical utility of ultrasonography in thyroid disease\", section on 'Goiter'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289428\">",
"    <span class=\"h3\">",
"     Thyroid scintigraphy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If thyroid tests are indicative of hyperthyroidism (low TSH, elevated free T4",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    T3) or subclinical hyperthyroidism (low TSH, normal free T4 and T3), the cause of the hyperthyroidism should be distinguished by the findings on the 24-hour radioiodine uptake and scan. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26520?source=see_link\">",
"     \"Diagnosis of hyperthyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/0/4103?source=see_link\">",
"     \"Disorders that cause hyperthyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289847\">",
"    <span class=\"h3\">",
"     Fine needle aspiration biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fine needle aspiration biopsy of goiter is indicated if there is a history of rapid growth, pain or tenderness; unusual firmness in one region of the goiter; or sonographically detected nodules with indeterminate or suspicious sonographic features. A history of rapid growth raises the suspicion of cancer, particularly anaplastic cancer or thyroid lymphoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/9\">",
"     9",
"    </a>",
"    ]. The selection of nodules for fine needle aspiration biopsy is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28506?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Fine needle aspiration biopsy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28056?source=see_link\">",
"     \"Thyroid biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11606530\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis in a patient presenting with a neck mass is extensive and varies with the age of the patient at presentation. Neck masses that are not goiter may be congenital (ie, vascular anomaly), inflammatory (lymph node enlargement), or neoplastic (primary or metastatic disease) disorders. The differential diagnosis of a neck mass is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/21/11608?source=see_link\">",
"     \"Differential diagnosis of a neck mass\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289214\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of management are to correct the underlying thyroid dysfunction, if present, and if the goiter is growing or causing obstructive symptoms, to decrease the size or prevent further growth of the goiter.",
"   </p>",
"   <p>",
"    Hypothyroidism should be treated with thyroid hormone (thyroxine, T4) replacement therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=see_link\">",
"     \"Treatment of hypothyroidism\"",
"    </a>",
"    .) Over time, treatment with thyroid hormone may reduce the size of the goiter, particularly in patients with Hashimoto&rsquo;s thyroiditis with elevated serum TSH levels. In many cases, however, the goiter does not resolve completely.",
"   </p>",
"   <p>",
"    The treatment of hyperthyroidism depends upon the underlying cause. The management of goiter (with or without thyroid dysfunction) also depends upon the cause. This section primarily focuses on the management of nontoxic diffuse or multinodular goiter. The treatment of toxic multinodular goiter, Graves&rsquo; disease, thyroiditis, and goiter due to iodine deficiency are reviewed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/30/41448?source=see_link\">",
"       \"Treatment of toxic adenoma and toxic multinodular goiter\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21143?source=see_link\">",
"       \"Treatment of Graves' hyperthyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/23/1399?source=see_link\">",
"       \"Subacute thyroiditis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/7/24694?source=see_link\">",
"       \"Painless thyroiditis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/59/39864?source=see_link&amp;anchor=H18#H18\">",
"       \"Iodine deficiency disorders\", section on 'Prophylaxis and treatment of the community'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62289899\">",
"    <span class=\"h2\">",
"     Nontoxic benign goiter",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no consensus on the ideal treatment of nontoxic benign goiter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The lack of consensus is due, in part, to the variable natural history of benign goiter. In some patients, the goiter gradually increases in size over time with the development of multiple nodules, compressive symptoms, and cosmetic concerns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/6\">",
"     6",
"    </a>",
"    ]. However, in up to 20 percent of women and 5 percent of men, the goiter stabilizes or spontaneously regresses over time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The options for management of nontoxic goiter include thyroidectomy, thyroid hormone suppression therapy, radioiodine, or monitoring. There are advantages and disadvantages of each option (",
"    <a class=\"graphic graphic_table graphicRef78621 \" href=\"mobipreview.htm?32/29/33244\">",
"     table 2",
"    </a>",
"    ). There are few trials comparing interventions. In one trial, 64 patients with sporadic nontoxic multinodular goiter (average size 60 mL) were randomly assigned to radioiodine (131-I, 120 &micro;Ci (4.44",
"    <span class=\"nowrap\">",
"     MBq)/g",
"    </span>",
"    thyroid) or suppressive",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    (T4) treatment (goal TSH between 0.01 and 0.1",
"    <span class=\"nowrap\">",
"     mU/L).",
"    </span>",
"    After two years, 97 percent of the patients treated with radioiodine and 43 percent of those treated with T4 had a decrease in goiter size. The median decrease in goiter size (by ultrasound) was 41 percent in the group treated with radioiodine compared with 5 percent in the suppressive levothyroxine treatment group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/13\">",
"     13",
"    </a>",
"    ]. Although none of the patients had overt hyperthyroidism, 17 had subclinical hyperthyroidism (low TSH, normal free thyroxine), which may bias the results in favor of radioiodine. Hypothyroidism developed in 45 percent of patients receiving radioiodine. Patients who were treated with suppressive doses of thyroid hormone were more likely to have thyrotoxic symptoms and a decrease in bone mineral density (mean decrease of 3.6 percent at the lumbar spine, compared with no change in the radioiodine group).",
"   </p>",
"   <p>",
"    There are no trials comparing 131-I with surgery. In the absence of adequate randomized trial data, management decisions should be individualized based upon patient factors, regional medical practices, and the following general principles (",
"    <a class=\"graphic graphic_table graphicRef78621 \" href=\"mobipreview.htm?32/29/33244\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The decision to perform thyroidectomy is based upon the results of fine needle aspiration biopsy of any nodule(s) that may be present and upon the presence of obstructive symptoms or other concomitant conditions such as hyperparathyroidism. (See",
"      <a class=\"local\" href=\"#H26292549\">",
"       'Surgery'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Radioiodine has traditionally been used to treat patients with hyperthyroidism and thyroid cancer, but it is in fact both safe and effective for select patients with nontoxic nodular goiter. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Radioiodine therapy'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The use of thyroid hormone suppressive therapy has declined due to concerns about potential side effects, particularly atrial arrhythmias and decreased bone density, as well as controversy regarding its efficacy. In addition, thyroid hormone suppressive therapy is not an option for patients with serum TSH concentrations at the lower limit of or below the normal range, because these patients already have endogenous suppression of TSH. (See",
"      <a class=\"local\" href=\"#H7285171\">",
"       'Thyroid hormone suppressive therapy for benign goiter'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/0/22535?source=see_link\">",
"       \"Thyroid hormone suppressive therapy for thyroid nodules and benign goiter\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Asymptomatic euthyroid patients with benign diffuse or multinodular goiters do not require any specific treatment but should be monitored for the development of thyroid dysfunction or for continued growth of the thyroid gland",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the development of obstructive symptoms. (See",
"      <a class=\"local\" href=\"#H62290008\">",
"       'Monitoring'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26292549\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with goiters that continue to grow, cause obstructive signs, symptoms, or cosmetic concerns, or extend substernally, we prefer surgery over radioiodine. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32742?source=see_link\">",
"     \"Treatment of obstructive or substernal goiter\"",
"    </a>",
"    .) In addition, patients with nodules within a goiter that are malignant or suspicious for malignancy on fine needle aspiration biopsy require surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28506?source=see_link&amp;anchor=H24#H24\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h3\">",
"     Radioiodine therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radioiodine therapy is infrequently used in the United States for the treatment of nontoxic goiter. Due to high dietary iodine intake, thyroid iodine uptake is typically low in patients with nontoxic goiter and, therefore, a relatively high dose of 131-I is required for goiter reduction. Radioiodine for the treatment of nontoxic nodular goiter is more commonly used in Europe, and in particular Denmark and The Netherlands.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7285136\">",
"    <span class=\"h4\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several observational studies, mostly from Europe, describing the effects of radioiodine therapy in over 300 patients with nontoxic multinodular goiter (average goiter size ranging from 60 to 269 mL) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/6,14-23\">",
"     6,14-23",
"    </a>",
"    ]. In most studies, the patients were elderly, had respiratory symptoms, dysphagia, or recent thyroid growth, and were considered poor surgical candidates or had refused surgery. Overall, the reported reduction in goiter size (as measured by ultrasound) ranged from 40 to 60 percent within one to two years of therapy, with most of the effect occurring in the first three months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/6\">",
"     6",
"    </a>",
"    ]. Obstructive symptoms improved in most patients. There are fewer observational studies of 131-I therapy for the treatment of nontoxic diffuse goiter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. In two studies, median thyroid volume reduction was 50 to 60 percent within one year of therapy.",
"   </p>",
"   <p>",
"    The factors determining outcome were analyzed in one study of 50 patients in whom the mean reduction in goiter size was 47 percent (median follow-up 41 months) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/21\">",
"     21",
"    </a>",
"    ]. Eleven patients (22 percent) had no decrease in goiter size or a transient decrease and then re-enlargement of their goiter. The reduction in goiter size was greater in younger patients; those with smaller goiters, a shorter history of goiter, or dominant nodules; and those given higher doses of radioiodine. The baseline serum thyrotropin (TSH) concentration was not a determinant of reduction in goiter size, but a higher (but still normal) value was associated with a higher risk of hypothyroidism. (See",
"    <a class=\"local\" href=\"#H7285816\">",
"     'Adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62290029\">",
"    <span class=\"h4\">",
"     Dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dose of radioiodine in these studies ranged from 75 to 400 microcuries",
"    <span class=\"nowrap\">",
"     (microCi)/g",
"    </span>",
"    tissue (2.8 to 14.8 megabecquerels",
"    <span class=\"nowrap\">",
"     [MBq]/g",
"    </span>",
"    tissue). Most patients received doses between 100 and 200",
"    <span class=\"nowrap\">",
"     microCi/g",
"    </span>",
"    (3.7 and 7.4",
"    <span class=\"nowrap\">",
"     MBq/g),",
"    </span>",
"    similar to those used to treat hyperthyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/7/12410?source=see_link\">",
"     \"Radioiodine in the treatment of hyperthyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The dose was usually calculated by the following formula:",
"   </p>",
"   <p>",
"    Dose (Activity) &nbsp;= &nbsp;(thyroid weight x desired radioiodine delivery to thyroid) &divide; radioiodine uptake",
"   </p>",
"   <p>",
"    The units are grams for thyroid weight and",
"    <span class=\"nowrap\">",
"     microCi/g",
"    </span>",
"    for radioiodine delivery; radioiodine uptake is expressed as a decimal (ie, 20 percent = 0.20).",
"   </p>",
"   <p>",
"    The 24-hour thyroid radioiodine uptake is considerably lower in patients with nontoxic multinodular goiter than in patients with Graves' hyperthyroidism or toxic multinodular goiter. As a result, the dose of radioiodine needed may exceed that permissible for outpatients, which varies from state-to-state in the United States and also among other countries.",
"   </p>",
"   <p>",
"    An alternative approach is to use multiple fractionated doses of radioiodine. When 60 mCi (2.22 GBq) was given in four divided monthly doses to patients with obstructive goiter in one report, 71 percent had improvement in symptoms related to compression of neck structures and 92 percent had a reduction in goiter size, but 66 percent became hypothyroid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/26\">",
"     26",
"    </a>",
"    ]. Slightly over one-half of the patients had toxic nodular goiter. Thus, it is uncertain whether the higher rate of hypothyroidism was due to the fractionated doses or higher retention of isotope in the hyperthyroid patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7285816\">",
"    <span class=\"h4\">",
"     Adverse effects",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7286421\">",
"    <span class=\"h5\">",
"     General",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radioiodine is generally well tolerated. In studies of radioiodine for the treatment of nontoxic benign goiter, the following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypothyroidism occurred in 22 to 58 percent of patients within one to eight years after treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/15-17,21,22\">",
"       15-17,21,22",
"      </a>",
"      ]. An additional 10 to 40 percent of patients had subclinical hypothyroidism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/14,17,19,21\">",
"       14,17,19,21",
"      </a>",
"      ], and treatment with T4 after radioiodine probably masked hypothyroidism in some other patients.",
"     </li>",
"     <li>",
"      Approximately 5 percent of patients had transient hyperthyroidism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/14,15,17,19,20\">",
"       14,15,17,19,20",
"      </a>",
"      ]. The mean serum free T4 and triiodothyronine concentrations transiently increased by 20 and 13 percent, respectively, in the first two weeks after treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Symptomatic radiation thyroiditis (thyroid pain and tenderness) was uncommon, occurring in 2 of 69 patients (3 percent) in one series [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/17\">",
"       17",
"      </a>",
"      ] and 4 of 32 patients (13 percent) in another series [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43830?source=see_link\">",
"       \"Overview of thyroiditis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Concerns that radioiodine therapy in patients with nontoxic multinodular goiter might cause early goiter enlargement, thereby leading to acute airway obstruction, have not materialized [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/18,22\">",
"       18,22",
"      </a>",
"      ]. However, in a study of patients with non-obstructive toxic multinodular goiter given radioiodine, 8 percent had an increase in goiter size (mean increase 23 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/27\">",
"       27",
"      </a>",
"      ], suggesting caution and careful monitoring in patients with severe tracheal narrowing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7285838\">",
"    <span class=\"h5\">",
"     Autoimmune hyperthyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two groups found that 4 to 5 percent of patients with nontoxic multinodular goiter treated with radioiodine developed a Graves' hyperthyroidism, with high serum concentrations of TSH receptor antibodies 3 to 10 months later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Another study of over 1350 patients found only 1.1 percent of patients developed autoimmune hyperthyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/30\">",
"     30",
"    </a>",
"    ]. However, this occurred up to 10 times more commonly in patients with high serum antithyroid peroxidase antibody concentrations before treatment (TSH receptor antibody tests were negative then in all patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. These patients were treated with an antithyroid drug or additional radioiodine. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21143?source=see_link\">",
"     \"Treatment of Graves' hyperthyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7285845\">",
"    <span class=\"h5\">",
"     Risk of cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on measurements of whole-body radiation exposure, one group calculated slightly increased estimated lifetime risk of nonthyroid cancer of about 1.6 percent because of the large doses of radioiodine used in patients with very large goiters (mean size 222 g) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/31\">",
"     31",
"    </a>",
"    ]. The risk is much less (about 0.5 percent) in patients above the age of 65 years, the age of most patients with nontoxic multinodular goiters large enough to require therapy. The risk of nonthyroid and thyroid cancer after radioiodine treatment of hyperthyroidism is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/7/12410?source=see_link&amp;anchor=H30632451#H30632451\">",
"     \"Radioiodine in the treatment of hyperthyroidism\", section on 'Cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h4\">",
"     Recombinant human TSH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pretreatment with recombinant human TSH (rhTSH, thyrotropin alpha) increases radioiodine uptake in nontoxic nodular goiter, and results in a more homogeneous distribution of uptake by stimulating uptake in relatively cold areas more than in relatively hot areas, particularly in those with low serum TSH concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. Thus, administration of rhTSH allows for treatment with lower doses of radioiodine without compromising efficacy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. It has been shown to be a useful adjunct to radioiodine for the treatment of nontoxic multinodular goiter, especially when the radioiodine uptake is low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. The proposed dose of rhTSH is much lower than is used for treatment and diagnostic testing in patients with thyroid cancer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34010?source=see_link&amp;anchor=H12#H12\">",
"     \"Radioiodine treatment of differentiated thyroid cancer\", section on 'Recombinant hTSH'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In prospective trials, radioiodine with rhTSH (0.1 to 0.45 mg administered 24 hours prior to radioiodine) was more effective in reducing goiter volume than radioiodine alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/35,40-42\">",
"     35,40-42",
"    </a>",
"    ]. As an example, in a randomized trial of radioiodine treatment calculated to give a thyroidal dose of 100 Gy administered 24 hours after rhTSH (0.3 mg) or placebo, patients receiving rhTSH had a greater reduction in goiter size at one year (62 versus 46 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/41\">",
"     41",
"    </a>",
"    ]. The median 131-I dose was similar in the two groups.",
"   </p>",
"   <p>",
"    In another trial, 90 patients with nontoxic nodular goiter (median size 63 mL) were randomly assigned to either 0.1 mg rhTSH and radioiodine (50 Gy) or placebo and radioiodine (100 Gy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/35\">",
"     35",
"    </a>",
"    ]. After 12 months, the mean reduction in goiter volume was identical (35 percent) even though the rhTSH group received half the dose of 131-I as the placebo group. Both groups reported improvement in goiter symptoms.",
"   </p>",
"   <p>",
"    Compared with radioiodine alone, the use of rhTSH prior to radioiodine is associated with a higher incidence of hypothyroidism (62 versus 11 percent in one trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/41\">",
"     41",
"    </a>",
"    ]). However, in the trial described above in which patients who were pretreated with rhTSH received one-half the dose of 131-I, the difference in the prevalence of hypothyroidism one year after treatment was not significant (12 versus 7 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/35\">",
"     35",
"    </a>",
"    ]. These results suggest that pretreatment with rhTSH allows a major reduction in radioiodine dose without changing efficacy. The reduction in radioiodine dose may facilitate outpatient treatment and reduce the risk of side effects.",
"   </p>",
"   <p>",
"    Long-term follow-up in two of these trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/41,42\">",
"     41,42",
"    </a>",
"    ] found that goiter volume was reduced further in all patients after a mean 71 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/43\">",
"     43",
"    </a>",
"    ]. The reduction in goiter volume remained higher in the rhTSH group (70 percent versus 56 percent in the group who received radioiodine without rhTSH), and the number of patients requiring additional therapy for obstructive symptoms was lower in the rhTSH group (5 percent versus 20 percent in the group who were not pretreated with rhTSH). The prevalence of hypothyroidism remained higher in the rhTSH group (52 versus 16 percent).",
"   </p>",
"   <p>",
"    A potential concern about pretreatment with rhTSH is an increase in goiter size after administration of rhTSH. This was illustrated in a study of 10 patients with nodular goiter given 0.3 mg of rhTSH who then experienced an increase in mean goiter size at 24 hours of 9.8 percent, and at 48 hours of 24 percent, returning to baseline at one week, suggesting that rhTSH could cause obstructive symptoms in patients with near obstructive goiters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/44\">",
"     44",
"    </a>",
"    ]. However, in another study using rhTSH to reduce goiter size in 14 patients with large goiters, the smallest cross sectional area of the trachea measured by magnetic resonance imaging (MRI) was found to be 10.5 percent greater one week after radioiodine administration, although the forced vital capacity was slightly reduced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/45\">",
"     45",
"    </a>",
"    ]. A modified release very low dose rhTSH preparation (0.01 to 0.03 mg) has been studied that results in lower peak serum TSH levels and therefore might be associated with less risk of goiter enlargement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neither regular nor modified release recombinant hTSH is approved by the US FDA or European Medicines Agency for use with radioiodine in the treatment of multinodular goiter. It is only available in kits of two vials of 0.9 mg (for use prior to administration of radioiodine to athyreotic thyroid cancer patients), and it is costly. We are therefore not presently recommending rhTSH prior to radioiodine administration of nontoxic goiter pending additional clinical trials determining optimal dosing, demonstrating safety, and confirming efficacy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7285171\">",
"    <span class=\"h3\">",
"     Thyroid hormone suppressive therapy for benign goiter",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of thyroid hormone suppressive therapy in euthyroid patients with sporadic non-toxic goiter is controversial, and its use has declined due to concerns about potential long-term side effects from the induction of subclinical hyperthyroidism. When used, thyroxine must be continued long-term as any reduction in goiter size during therapy is lost upon discontinuation of thyroxine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/44\">",
"     44",
"    </a>",
"    ]. In the absence of a history of childhood neck radiation, we do not routinely treat patients with thyroid hormone suppressive therapy. This topic is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/0/22535?source=see_link\">",
"     \"Thyroid hormone suppressive therapy for thyroid nodules and benign goiter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62290008\">",
"    <span class=\"h3\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Euthyroid patients with asymptomatic diffuse goiters or benign multinodular goiters (confirmed by fine needle aspiration biopsy) require no immediate treatment. However, they should be followed with periodic neck exams and thyroid function tests (TSH). For patients with benign multinodular goiter, we also monitor with thyroid ultrasound (initially annually for three years, then at increasing intervals, eg, three to five years). Neck computed tomography (CT) or MRI may be necessary if there is retrosternal extent of the goiter. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations and evaluation of obstructive or substernal goiter\", section on 'Radiologic testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with very large goiters (&gt;80 to 100 mL), we prefer active treatment rather than monitoring because of concern regarding continuous growth and possible development of thyroid autonomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26292665\">",
"    <span class=\"h2\">",
"     Goitrous Hashimoto's",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hashimoto's thyroiditis (chronic autoimmune thyroiditis) is the most common cause of hypothyroidism in iodine-sufficient areas of the world. It is characterized clinically by gradual thyroid failure, goiter formation, or both, due to autoimmune-mediated destruction of the thyroid gland involving apoptosis of thyroid epithelial cells. The two major forms of the disorder are goitrous autoimmune thyroiditis and atrophic autoimmune thyroiditis. Although the thyroid enlargement that can occur in patients with goitrous autoimmune thyroiditis is usually asymptomatic, rare patients have significant thyroid enlargement, sometimes with thyroid pain and tenderness. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/11/27833?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis of Hashimoto's thyroiditis (chronic autoimmune thyroiditis)\", section on 'Clinical characteristics'",
"    </a>",
"    .) Such patients may require surgery for symptomatic relief. There is one report of the use of radioiodine in goitrous Hashimoto's thyroiditis unresponsive to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    suppressive therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/27/32185/abstract/47\">",
"     47",
"    </a>",
"    ]. Thirteen patients received two to six doses of 13 mCi radioiodine at one to six month intervals, which resulted in a 59 percent reduction in goiter size.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/9/22674?source=see_link\">",
"       \"Patient information: Hyperthyroidism (overactive thyroid) (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/4/23618?source=see_link\">",
"       \"Patient information: Thyroid nodules (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/12/30914?source=see_link\">",
"       \"Patient information: Multinodular goiter (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?3/6/3172?source=see_link\">",
"       \"Patient information: Hyperthyroidism (overactive thyroid) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/15/23794?source=see_link\">",
"       \"Patient information: Antithyroid drugs (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/16/18691?source=see_link\">",
"       \"Patient information: Thyroid nodules (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinical manifestations of goiter depend upon the presence of thyroid dysfunction and upon the growth rate of the goiter. Some patients may have symptoms of hypothyroidism or hyperthyroidism. However, the majority of patients with goiter are asymptomatic. Patients with long-standing goiters may develop symptoms of obstruction, due to progressive compression of the trachea or sudden enlargement (usually accompanied by pain) secondary to hemorrhage into a nodule. (See",
"      <a class=\"local\" href=\"#H62289353\">",
"       'Clinical presentation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14503?source=see_link\">",
"       \"Clinical manifestations of hypothyroidism\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/60/14279?source=see_link\">",
"       \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"       \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The diagnosis of a goiter is usually made at the time of a physical examination. One or more discrete nodules may be palpable. Goiter may also be an incidental finding during a radiologic procedure performed for other purposes (eg, carotid ultrasound). Once goiter is detected, the diagnostic evaluation is aimed at assessment of its size and the presence of nodules, identifying whether there are compressive or obstructive symptoms, assessing thyroid function, and identifying the underlying cause (",
"      <a class=\"graphic graphic_table graphicRef67399 \" href=\"mobipreview.htm?16/53/17244\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H62289328\">",
"       'Diagnostic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial evaluation in patients with goiter (discovered either by palpation or incidentally noted on a radiologic procedure) is measurement of serum thyroid stimulating hormone (TSH). Ultrasound should be obtained in patients with nontoxic goiter unrelated to Hashimoto&rsquo;s thyroiditis or iodine deficiency to assess sonographic features, the presence of nodularity, and the presence of lymphadenopathy. In patients with goiter due to Hashimoto&rsquo;s thyroiditis or iodine deficiency, ultrasound should be reserved for patients with thyroid asymmetry or palpable nodules. (See",
"      <a class=\"local\" href=\"#H62289413\">",
"       'Thyroid function tests'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H62289421\">",
"       'Thyroid ultrasound'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If thyroid tests show hyperthyroidism (low TSH, elevated free T4",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      T3) or subclinical hyperthyroidism (low TSH, normal free T4 and T3), the cause of the hyperthyroidism should be distinguished by the findings on the 24-hour radioiodine uptake and scan. (See",
"      <a class=\"local\" href=\"#H62289428\">",
"       'Thyroid scintigraphy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fine needle aspiration biopsy of goiter is indicated if there is a history of rapid growth, pain, or tenderness; unusual firmness in one region of the goiter; or sonographically detected nodules with indeterminate or suspicious sonographic features. (See",
"      <a class=\"local\" href=\"#H62289847\">",
"       'Fine needle aspiration biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goals of management are to correct the underlying thyroid dysfunction, if present, and to decrease the size or prevent further growth of the goiter. In the absence of adequate randomized trial data, management decisions should be individualized based upon patient characteristics (",
"      <a class=\"graphic graphic_table graphicRef78621 \" href=\"mobipreview.htm?32/29/33244\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H62289214\">",
"       'Management'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Patients with nodules within a goiter that are malignant or suspicious for malignancy on fine needle aspiration biopsy require surgery. (See",
"      <a class=\"local\" href=\"#H26292549\">",
"       'Surgery'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28506?source=see_link&amp;anchor=H24#H24\">",
"       \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Management'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Patients with goiter causing obstructive signs or symptoms require treatment. We suggest surgery rather than RAI (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The reduction in thyroid volume with RAI is only moderate, the treated goiter requires continued monitoring for growth, and periodic imaging may raise concerns of a missed malignancy. For patients with obstructive symptoms who are poor surgical candidates, we suggest radioiodine therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26292549\">",
"       'Surgery'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32742?source=see_link&amp;anchor=H3#H3\">",
"       \"Treatment of obstructive or substernal goiter\", section on 'Surgery'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      For patients with very large benign goiters (&gt;80 g) who do not have obstructive symptoms but desire treatment, we suggest surgery or radioiodine rather than thyroid hormone suppressive therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Radioiodine may be especially useful for those patients with low-normal or low serum TSH concentrations whose goiters have autonomous areas with relatively higher radioiodine uptake. Until additional clinical trial data confirm efficacy and demonstrate safety, we are not routinely using rhTSH prior to radioiodine administration of nontoxic goiter. Observation is appropriate in many asymptomatic patients who do not have cosmetic concerns. (See",
"      <a class=\"local\" href=\"#H26292549\">",
"       'Surgery'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Radioiodine therapy'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      For euthyroid patients with asymptomatic diffuse goiters (&lt;80 g) or benign multinodular goiters (confirmed by fine needle aspiration biopsy), we suggest observation rather than active treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In such patients, we monitor TSH and physical examination yearly. In patients with multinodular goiter, we perform thyroid ultrasound yearly for the first three years and then less frequently thereafter if the goiter is stable. (See",
"      <a class=\"local\" href=\"#H62290008\">",
"       'Monitoring'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/1\">",
"      Knudsen N, Perrild H, Christiansen E, et al. Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 2000; 142:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/2\">",
"      Marqusee E, Benson CB, Frates MC, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 2000; 133:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/3\">",
"      ul Haq RN, Khan BA, Chaudhry IA. Prevalence of malignancy in goitre--a review of 718 thyroidectomies. J Ayub Med Coll Abbottabad 2009; 21:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/4\">",
"      Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 1990; 89:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/5\">",
"      Elte JW, Bussemaker JK, Haak A. The natural history of euthyroid multinodular goitre. Postgrad Med J 1990; 66:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/6\">",
"      Heged&uuml;s L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003; 24:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/7\">",
"      Heged&uuml;s L. Thyroid ultrasound. Endocrinol Metab Clin North Am 2001; 30:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/8\">",
"      Bahn RS, Castro MR. Approach to the patient with nontoxic multinodular goiter. J Clin Endocrinol Metab 2011; 96:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/9\">",
"      Madjar S, Weissberg D. Retrosternal goiter. Chest 1995; 108:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/10\">",
"      Bonnema SJ, Bennedbaek FN, Ladenson PW, Heged&uuml;s L. Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 2002; 87:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/11\">",
"      Bonnema SJ, Bennedbaek FN, Wiersinga WM, Heged&uuml;s L. Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol (Oxf) 2000; 53:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/12\">",
"      Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/13\">",
"      Wesche MF, Tiel-V Buul MM, Lips P, et al. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001; 86:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/14\">",
"      Kay TW, d'Emden MC, Andrews JT, Martin FI. Treatment of non-toxic multinodular goiter with radioactive iodine. Am J Med 1988; 84:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/15\">",
"      Heged&uuml;s L, Hansen BM, Knudsen N, Hansen JM. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. BMJ 1988; 297:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/16\">",
"      Verelst J, Bonnyns M, Glinoer D. Radioiodine therapy in voluminous multinodular non-toxic goitre. Acta Endocrinol (Copenh) 1990; 122:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/17\">",
"      Nygaard B, Heged&uuml;s L, Gervil M, et al. Radioiodine treatment of multinodular non-toxic goitre. BMJ 1993; 307:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/18\">",
"      Nygaard B, Faber J, Heged&uuml;s L. Acute changes in thyroid volume and function following 131I therapy of multinodular goitre. Clin Endocrinol (Oxf) 1994; 41:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/19\">",
"      Wesche MF, Tiel-v-Buul MM, Smits NJ, Wiersinga WM. Reduction in goiter size by 131I therapy in patients with non-toxic multinodular goiter. Eur J Endocrinol 1995; 132:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/20\">",
"      Huysmans DA, Hermus AR, Corstens FH, et al. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994; 121:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/21\">",
"      LeMoll, R, Wesche, MF, Tiel-van-Buul, MM, et al. Determinants of longterm outcome of radioiodine in sporadic non-toxic goiter. Clin Endocrinol 1999; 50:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/22\">",
"      Bonnema SJ, Bertelsen H, Mortensen J, et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 1999; 84:3636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/23\">",
"      Villadsen MJ, S&oslash;rensen CH, Godballe C, Nygaard B. Need for thyroidectomy in patients treated with radioactive iodide for benign thyroid disease. Dan Med Bull 2011; 58:A4343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/24\">",
"      Heged&uuml;s L, Bennedbaek FN. Radioiodine for non-toxic diffuse goitre. Lancet 1997; 350:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/25\">",
"      Nygaard B, Farber J, Veje A, Hansen JE. Thyroid volume and function after 131I treatment of diffuse non-toxic goitre. Clin Endocrinol (Oxf) 1997; 46:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/26\">",
"      Howarth DM, Epstein MT, Thomas PA, et al. Outpatient management of patients with large multinodular goitres treated with fractionated radioiodine. Eur J Nucl Med 1997; 24:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/27\">",
"      Nygaard B, Heged&uuml;s L, Ulriksen P, et al. Radioiodine therapy for multinodular toxic goiter. Arch Intern Med 1999; 159:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/28\">",
"      Huysmans AK, Hermus RM, Edelbroek MA, et al. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid 1997; 7:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/29\">",
"      Nygaard B, Knudsen JH, Heged&uuml;s L, et al. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 1997; 82:2926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/30\">",
"      Schmidt M, Gorbauch E, Dietlein M, et al. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease. Thyroid 2006; 16:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/31\">",
"      Huysmans DA, Buijs WC, van de Ven MT, et al. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters. J Nucl Med 1996; 37:2072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/32\">",
"      Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, et al. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 2000; 85:3592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/33\">",
"      Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, et al. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 2001; 86:5330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/34\">",
"      Fast S, Nielsen VE, Grupe P, et al. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study. J Nucl Med 2009; 50:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/35\">",
"      Fast S, Heged&uuml;s L, Grupe P, et al. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. J Clin Endocrinol Metab 2010; 95:3719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/36\">",
"      Nieuwlaat WA, Huysmans DA, van den Bosch HC, et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 2003; 88:3121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/37\">",
"      Bonnema SJ, Heged&uuml;s L. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter. Curr Opin Endocrinol Diabetes Obes 2009; 16:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/38\">",
"      Duntas LH, Cooper DS. Review on the occasion of a decade of recombinant human TSH: prospects and novel uses. Thyroid 2008; 18:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/39\">",
"      Albino CC, Mesa CO Jr, Olandoski M, et al. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 2005; 90:2775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/40\">",
"      Silva MN, Rubi&oacute; IG, Rom&atilde;o R, et al. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 2004; 60:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/41\">",
"      Nielsen VE, Bonnema SJ, Boel-J&oslash;rgensen H, et al. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 2006; 166:1476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/42\">",
"      Bonnema SJ, Nielsen VE, Boel-J&oslash;rgensen H, et al. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab 2007; 92:3424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/43\">",
"      Fast S, Nielsen VE, Grupe P, et al. Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter. J Clin Endocrinol Metab 2012; 97:2653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/44\">",
"      Nielsen VE, Bonnema SJ, Heged&uuml;s L. Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial. J Clin Endocrinol Metab 2006; 91:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/45\">",
"      Bonnema SJ, Nielsen VE, Boel-J&oslash;rgensen H, et al. Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration. J Clin Endocrinol Metab 2008; 93:3981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/46\">",
"      Graf H, Fast S, Pacini F, et al. Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study. J Clin Endocrinol Metab 2011; 96:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/27/32185/abstract/47\">",
"      Tajiri J. Radioactive iodine therapy for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 2006; 91:4497.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7835 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-543E46505B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32185=[""].join("\n");
var outline_f31_27_32185=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H62289320\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10798374\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H62289328\">",
"      DIAGNOSTIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H62289353\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H62289336\">",
"      Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H62289413\">",
"      - Thyroid function tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H62289421\">",
"      - Thyroid ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H62289428\">",
"      - Thyroid scintigraphy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H62289847\">",
"      - Fine needle aspiration biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11606530\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H62289214\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H62289899\">",
"      Nontoxic benign goiter",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26292549\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      - Radioiodine therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H7285136\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H62290029\">",
"      Dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H7285816\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H7286421\">",
"      - General",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H7285838\">",
"      - Autoimmune hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H7285845\">",
"      - Risk of cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Recombinant human TSH",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7285171\">",
"      - Thyroid hormone suppressive therapy for benign goiter",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H62290008\">",
"      - Monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26292665\">",
"      Goitrous Hashimoto's",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7835\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7835|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/53/17244\" title=\"table 1\">",
"      Causes of goiter in adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/29/33244\" title=\"table 2\">",
"      Advantages and disadvantages of treatment in nontoxic MNG",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/10/23721?source=related_link\">",
"      Anaplastic thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=related_link\">",
"      Clinical manifestations and evaluation of obstructive or substernal goiter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26744?source=related_link\">",
"      Diagnosis of and screening for hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26520?source=related_link\">",
"      Diagnosis of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28506?source=related_link\">",
"      Diagnostic approach to and treatment of thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/21/11608?source=related_link\">",
"      Differential diagnosis of a neck mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/0/4103?source=related_link\">",
"      Disorders that cause hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/47/42744?source=related_link\">",
"      Disorders that cause hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/15/43257?source=related_link\">",
"      Infiltrative thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/59/39864?source=related_link\">",
"      Iodine deficiency disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/60/14279?source=related_link\">",
"      Overview of the clinical manifestations of hyperthyroidism in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/62/21482?source=related_link\">",
"      Overview of the clinical utility of ultrasonography in thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43830?source=related_link\">",
"      Overview of thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/7/24694?source=related_link\">",
"      Painless thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/30/40425?source=related_link\">",
"      Pathogenesis of Graves' disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/11/27833?source=related_link\">",
"      Pathogenesis of Hashimoto's thyroiditis (chronic autoimmune thyroiditis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/15/23794?source=related_link\">",
"      Patient information: Antithyroid drugs (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?3/6/3172?source=related_link\">",
"      Patient information: Hyperthyroidism (overactive thyroid) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/9/22674?source=related_link\">",
"      Patient information: Hyperthyroidism (overactive thyroid) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/12/30914?source=related_link\">",
"      Patient information: Multinodular goiter (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/16/18691?source=related_link\">",
"      Patient information: Thyroid nodules (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/4/23618?source=related_link\">",
"      Patient information: Thyroid nodules (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/7/12410?source=related_link\">",
"      Radioiodine in the treatment of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34010?source=related_link\">",
"      Radioiodine treatment of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/23/1399?source=related_link\">",
"      Subacute thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28056?source=related_link\">",
"      Thyroid biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/0/22535?source=related_link\">",
"      Thyroid hormone suppressive therapy for thyroid nodules and benign goiter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/8/35974?source=related_link\">",
"      Thyroid lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21143?source=related_link\">",
"      Treatment of Graves' hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32742?source=related_link\">",
"      Treatment of obstructive or substernal goiter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/30/41448?source=related_link\">",
"      Treatment of toxic adenoma and toxic multinodular goiter",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_27_32186="Brunsting-Perry pemphigoid";
var content_f31_27_32186=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54769%7EDERM%2F73874%7EDERM%2F63997%7EDERM%2F54207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54769%7EDERM%2F73874%7EDERM%2F63997%7EDERM%2F54207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Brunsting-Perry pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erosions leading to scarring on scalp skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Mucous membrane pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Desquamative gingivitis with edema and hemorrhage in this patient with mucous membrane pemphigoid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Mucous membrane pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mucosal erosions on the gingiva and palate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Stage 3 ocular cicatricial pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the symblepharon bridging between the eyeball and the eyelid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32186=[""].join("\n");
var outline_f31_27_32186=null;
var title_f31_27_32187="Side effects pulse CTX in SLE";
var content_f31_27_32187=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F62047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F62047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adverse reactions to pulse methylprednisolone and pulse cyclophosphamide in lupus nephritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Side effect",
"       </td>",
"       <td class=\"subtitle1\">",
"        Methylprednisolone, 1 g/m",
"        <sup>",
"         2",
"        </sup>",
"        per month IV for one year, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cyclophosphamide monthly pulse IV for 6 months and then q 3 months, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Both",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amenorrhea",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        52",
"       </td>",
"       <td>",
"        57",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cervical dysplasia",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avascular necrosis",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        18",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Herpes zoster",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All infections",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Death",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Gourley MF, Austin HA, Scott D, et al. Ann Intern Med 1996; 125:549.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32187=[""].join("\n");
var outline_f31_27_32187=null;
var title_f31_27_32188="Cause vulval contact dermatitis";
var content_f31_27_32188=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of vulval contact dermatitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Irritants",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Soaps, bubble bath, shampoo",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sanitary or incontinence pads, tampons",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Nylon underwear",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sweat, urine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Talcum powder",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vaginal or vulvar medications",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Douches",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vaginal hygiene products",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vaginal contraceptive products",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Methylated spirits",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tea tree oil",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pinetarsol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Alcohol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Perfumes, deodorants",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hair conditioner",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chemically treated clothing, toilet paper, or water",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Allergens",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Benzocaine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neomycin",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chlorhexidine (in KY jelly)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ethylene diamine (in neomycin)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Perfumes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Propylene glycol and other preservatives",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tea tree oil",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Imidazole",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Latex (eg, condom, diaphragm)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Semen",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Disinfectants",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lanolin",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dyes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Nickel",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32188=[""].join("\n");
var outline_f31_27_32188=null;
var title_f31_27_32189="Genetic abnormalities LQTS";
var content_f31_27_32189=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58151&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58151&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Genetics of the long QT syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"11\" width=\"9%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT1",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT2",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT3",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT4",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT5",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT6",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT7",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT8",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT9",
"       </td>",
"       <td class=\"subtitle1\">",
"        LQT10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Chromosome locus",
"        </strong>",
"       </td>",
"       <td>",
"        11p15.6",
"       </td>",
"       <td>",
"        7q35-36",
"       </td>",
"       <td>",
"        3p21-24",
"       </td>",
"       <td>",
"        4q25-27",
"       </td>",
"       <td>",
"        21q22.1-22.2",
"       </td>",
"       <td>",
"        21q22.1-22.2",
"       </td>",
"       <td>",
"        17q23",
"       </td>",
"       <td>",
"        1q23",
"       </td>",
"       <td>",
"        3p25",
"       </td>",
"       <td>",
"        11q23.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Gene mutation/protein",
"        </strong>",
"       </td>",
"       <td>",
"        KvLQ1",
"       </td>",
"       <td>",
"        HERG",
"       </td>",
"       <td>",
"        SCN5A",
"       </td>",
"       <td>",
"        Ankyrin-B",
"       </td>",
"       <td>",
"        KCNE1*",
"       </td>",
"       <td>",
"        KCNE2*",
"       </td>",
"       <td>",
"        KCNJ2",
"       </td>",
"       <td>",
"        CACNA1C",
"       </td>",
"       <td>",
"        CAV3",
"       </td>",
"       <td>",
"        SCN4B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Current/channel (subunit)",
"        </strong>",
"       </td>",
"       <td>",
"        IKs (&alpha;)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        IKr",
"       </td>",
"       <td>",
"        INa",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        IKs (&beta;)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        IKr",
"       </td>",
"       <td>",
"        Klr2.1",
"       </td>",
"       <td>",
"        Gain of fxn - channel does not inactivate",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Increase in late sodium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Channel function",
"        </strong>",
"       </td>",
"       <td>",
"        Reduced function",
"       </td>",
"       <td>",
"        Reduced function",
"       </td>",
"       <td>",
"        Gain of function",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        Reduced function",
"       </td>",
"       <td>",
"        Reduced function",
"       </td>",
"       <td>",
"        Reduced function",
"       </td>",
"       <td>",
"        Gain of function",
"       </td>",
"       <td>",
"        Effects SCN5A - gain of function",
"       </td>",
"       <td>",
"        This is one of 4 Na",
"        <sub>",
"         v&beta;",
"        </sub>",
"        subunits - critical role in cell adhesion, signal transduction, and channel expression at the plasma membrane, and voltage dependence of channel gating",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Action potential",
"        </strong>",
"       </td>",
"       <td>",
"        Delayed phase 3",
"       </td>",
"       <td>",
"        Delayed phase 3",
"       </td>",
"       <td>",
"        Prolonged phase 2",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        Delayed phase 3",
"       </td>",
"       <td>",
"        Delayed phase 3",
"       </td>",
"       <td>",
"        Delayed phase 3",
"       </td>",
"       <td>",
"        Delayed phase 3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Prolong the action potential plateau",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"11\">",
"        <strong>",
"         Clinical syndrome",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Heterozygous mutation",
"       </td>",
"       <td class=\"sublist_other\">",
"        R-W",
"       </td>",
"       <td class=\"sublist_other\">",
"        R-W",
"       </td>",
"       <td class=\"sublist_other\">",
"        R-W",
"       </td>",
"       <td class=\"sublist_other\">",
"        R-W",
"       </td>",
"       <td class=\"sublist_other\">",
"        R-W",
"       </td>",
"       <td class=\"sublist_other\">",
"        R-W",
"       </td>",
"       <td class=\"sublist_other\">",
"        HPP",
"       </td>",
"       <td class=\"sublist_other\">",
"        R-W",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        R-W and 2:1 AVB",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Homozygous mutation",
"       </td>",
"       <td class=\"sublist_other\">",
"        J-L-N",
"       </td>",
"       <td class=\"sublist_other\">",
"        NR",
"       </td>",
"       <td class=\"sublist_other\">",
"        NR",
"       </td>",
"       <td class=\"sublist_other\">",
"        NR",
"       </td>",
"       <td class=\"sublist_other\">",
"        J-L-N",
"       </td>",
"       <td class=\"sublist_other\">",
"        NR",
"       </td>",
"       <td class=\"sublist_other\">",
"        NR",
"       </td>",
"       <td class=\"sublist_other\">",
"        None",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     R-W: Romano-Ward syndrome; J-L-N: Jervell and Lange-Nielsen syndrome with deafness; NR: not reported; HPP: hypokalemia periodic paralysis.",
"     <br/>",
"     * KCNE1 is also referred to as minK; KCNE2 is also referred to as MiRP1 (minK related protein 1).",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     The KvLQT1 gene encodes the alpha-subunit protein of the IKs channel, with the KCNE1 gene encoding the beta- subunit protein of this same channel. The alpha- and beta-subunit proteins combine together to form a cardiac potassium channel expressing the IKs (slowly activating component of delayed rectifier potassium current); Ikr is the rapidly activating component of delayed rectifier potassium current.",
"    </div>",
"    <div class=\"reference\">",
"     Amended with permission from: Schwartz PJ, Priori SG, Napolitano C. Long QT syndrome in Zipes DP, Jalife J (Eds.) Cardiac Electrophysiology: From Cell to Bedside. Orlando, Fla: WB Saunders. 1999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32189=[""].join("\n");
var outline_f31_27_32189=null;
var title_f31_27_32190="Motivational interviewing technique - Focusing";
var content_f31_27_32190=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F87243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F87243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Motivational interviewing technique - Focusing",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Non-motivational interview (MI) approach: Focusing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In the first vignette, a doctor uses a standard checklist approach to review issues with a cardiac rehabilitation patient. MI-inconsistent techniques are identified following the physician's statements.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        Hi Mr. Y, I'm Doctor A. It's nice to meet you. I have your chart here. I see you've had a rough time of it lately.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Yes, I never thought I'd have a heart attack. Now the nurses have me half scared to death that I'll have another one if I don't change my life completely.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        Well, it's their job to give you the information you need. (Ignoring patient emotions) So my job is to review how you're doing in a number of areas, and to set some goals for you to keep your heart as healthy as possible. (Providing information)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Okay.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        So for most people, the big areas are, first, cholesterol and lipids, which are related to diet, exercise, genetics, and medicines, and second, personal habits like smoking, drinking, being too sedentary or too stressed. (Providing information) Let's go through the list and see what you might do to improve your heart health. (Non-collaborative agenda setting)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Okay.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        I see you're a non-smoker, so that's great - one less thing to worry about! (Providing information)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Yes, and I don't drink much either. But I do have a lot of stress.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        So, how much are you drinking, typically? (Ignoring opportunity to reflect on drinking or stress)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Oh, a few beers a week. Maybe wine with dinner out once a week.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        So when you say a few, how many per night do you mean? (Closed question)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Well, probably three or four beers a night on work nights to relax. I have put on weight - now I have this beer gut - as I've gotten older and work at a desk job all day.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        So, are you thinking about cutting down on your beer, and getting rid of that beer gut with some exercise? (Closed question) You're drinking more than the limit for a healthy man. (Providing information) And one of the best things for your heart is brisk walking 45 to 60 minutes a day, four to five times a week. (Providing information) You probably should substitute walking for drinking those beers! (Providing advice without permission)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Well, I could walk my dog each afternoon, but I really like the beer to unwind after work.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        That sounds great - healthy for you and your dog! I have some brochures here about steps to take to cut down your drinking. (Providing information) Take these home, read them over, and then when you come back you can tell me how you did! (Providing advice without permission)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Well, okay...",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        This conversation, rather than helping the patient focus on a realistic, achievable, and meaningful change, is likely to result in him leaving less internally motivated, and more helpless to make a long list of changes. The doctor overlooks the opportunity to reflect the patient's perspective, and misses the life context that can serve as a facilitator of, or a barrier to, healthy change.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Motivational interviewing (MI) approach: Focusing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In contrast, let's review an MI-consistent conversation during the process of focusing.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        Hi Mr. Y, I'm Doctor A. It's nice to meet you. I have your chart here. I see you've had a rough time of it lately.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Yes, I never thought I'd have a heart attack. Now the nurses have me half scared to death that I'll have another one if I don't change my life completely.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        It's been a frightening experience in many ways. (Reflection) It seems like you have to change your whole life immediately, or risk another attack. (Complex reflection) I'm really glad you're here today. (Affirmation) While I know a lot about the heart, your rehabilitation after a heart attack isn't just up to me. It's a team effort. You are the expert on you, and what's realistic for you. (Providing information, inviting collaboration) I see my job right now as guiding you through a number of areas, to select one or two you are most ready to adjust, not to push you to make changes all at once. (Providing information, agenda setting) We'll figure out together where you're likely to get the most gain, and which other areas can be set aside for now. (Providing information, agenda setting) Together, we can figure out some small, achievable changes that will help you to keep your heart as healthy as possible. (Providing information)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Okay - wow, that's a relief. It sounds like I might be able to make some small adjustments that will help, rather than overhauling everything right away.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        That's right. (Affirmation) Changes you can make, that you can live with, are more likely to stick. (Providing information) What areas are you thinking about changing? (Open question)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Well, clearly I need to lose some weight, and get rid of my beer gut.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        Tell me about your exercise and drinking habits up until now. (Open question)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Well, I don't get much exercise. I'm penned up in an office most of the time, and when I'm stressed, I like to unwind with a few beers.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        It's been hard for you to be active. (Reflection) Your job makes you feel a bit penned in. (Reflection) And when you're stressed, it's relaxes you to have a few beers. (Reflection)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Right. But I have been thinking about what the nurses told me, to walk more, and even across the day. So I'm considering how to walk more frequently, but I'm not really wanting to cut out my beer completely.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        You really have been giving this a lot of thought. (Affirmation) You're right, some exercise changes could get you a lot of benefit, heart-wise. (Providing information) You're thinking about how to incorporate more walking, and also considering whether to do anything about your beer intake, but you're not sure about that one yet. (Reflection) Tell me a little more about how beer fits in your day. (Open question)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Well, when I get home, I'm pretty tense. I like to have a beer or two before dinner. Then we usually have wine with dinner, but just a glass of red wine, good for the heart, you know? Maybe later I'll have one or two more beers, but not every day.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        So beer before dinner, one or two to relax, then a glass of red wine with dinner, and sometimes a couple of beers later on. So maybe between three and five drinks each day.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Well, and on the weekends, sometimes more, if I go fishing or to the races. Maybe two six-packs on those weekend days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        Beer is a part of your routine for relaxing and also for your social and recreational time.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Yeah, I guess so, and thinking about it now, I must be drinking about 36 beers a week. That seems like a lot, now that we are talking about it. No wonder I got this beer gut.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        You're adding it up, and it's more than you realized. It might account for putting on that weight in the middle. (Complex reflection) What do you make of this, now that we're talking about it? (Open question)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Well, I think I should cut back. I'd like to lose this extra weight, and find some other way to deal with my stress. I'm not sure what to do though, instead of enjoying a beer.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        You're making a commitment to get healthy, and now you're considering how to get there. (Reflection)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Patient:",
"        </strong>",
"        Yeah. So I'm interested in your thoughts about how to get started.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Doctor:",
"        </strong>",
"        Okay, so we'll work together to create a plan that can work for you. (Collaborative spirit, conveying optimism, providing information)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32190=[""].join("\n");
var outline_f31_27_32190=null;
var title_f31_27_32191="Diagnosis anxiety disorder";
var content_f31_27_32191=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F63149&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F63149&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 584px\">",
"   <div class=\"ttl\">",
"    Algorithm for diagnosis of anxiety disorders",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 564px; height: 379px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005; 19:56. Copyright &copy;2005 Sage Publications, Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_27_32191=[""].join("\n");
var outline_f31_27_32191=null;
